{"Title": ["Geron Corporation (Delaware) (GERN) Q1 2020 Earnings Call Transcript", "EARNINGS SUMMARY: Details of Geron Corporation Q1 Earnings Report", "Geron Q1 20 Earnings Conference Call At 4:30 PM ET", "BUZZ-U.S. STOCKS ON THE MOVE-Tetraphase Pharma, Aurora Cannabis, HPE", "Why Geron Stock Soared 23.4% Today", "3 \u201cStrong Buy\u201d Penny Stocks With Triple-Digit Upside", "7 Penny Stocks To Buy with Massive Upside Potential", "Geron : Clinical Trial Activities Impacted By COVID-19 Pandemic, Cuts Spending", "Geron Corporation (Delaware) (GERN) Q1 2020 Earnings Call Transcript", "Geron Corporation (Delaware) (GERN) Q4 2019 Earnings Call Transcript", "EARNINGS SUMMARY: Details of Geron Corporation Q4 Earnings Report", "Geron Q4 19 Earnings Conference Call At 4:30 PM ET", "Is Geron Stock a Buy?", "7 Healthcare Stocks With 100% Street Support", "Does Geron Corporation Stock Belong in Your Portfolio in 2020?", "Better Buy: Geron vs. Incyte", "Better Buy: Geron vs. Acceleron", "EARNINGS SUMMARY: Details of Geron Corporation Q3 Earnings Report", "Better Buy: Geron vs. Celgene", "Health Care Sector Update for 10/11/2019: CLVS,GERN,ACRS,HEXO,HEXO.TO", "Health Care Sector Update for 10/11/2019: GERN,ACRS,HEXO", "Health Care Sector Update for 10/11/2019: ACRS, GERN, GILD, GLPG, JNJ, PFE, ABT, MRK, AMGN", "3 Top Small-Cap Stocks to Buy in October", "Health Care Sector Update for 10/01/2019: EYES,BCDA,GERN,NLNK", "Geron Corporation (Delaware) (GERN) Q3 2019 Earnings Call Transcript", "Health Care Sector Update for 10/01/2019: GERN, GNFT, ANAB, JNJ, PFE, ABT, MRK, AMGN", "2 Biotech Stocks I Wouldn't Touch With a Broom", "Geron Corporation (Delaware) (GERN) Q2 2019 Earnings Call Transcript", "What You'll Want to Know About Geron's Q2 Results", "Why Geron Corporation Stock Bolted Higher in the First Half of 2019", "Did Geron's Big Announcement Just Go Unnoticed?", "3 Cancer Treatment Stocks to Buy in April", "Why Geron Stock Is Jumping Today", "Health Care Sector Update for 10/01/2019: GERN, GNFT, ANAB, JNJ, PFE, ABT, MRK, AMGN", "2 Biotech Stocks I Wouldn't Touch With a Broom", "Geron Corporation (Delaware) (GERN) Q2 2019 Earnings Call Transcript", "Geron Corportaion (GERN) Q4 2018Earnings Conference Call Transcript", "Earnings Reaction History: GERON CORP, 71.4% Follow-Through Indicator, 13.5% Sensitive", "Why Geron Skyrocketed 27% in February", "The 3 Oldest Members of Biotech's Billion-Burned Club", "3 Penny Stocks That Could Make You Rich -- or Regretful", "Why Geron Stock Briefly Spiked Today", "Are Options Traders Betting on a Big Move in Geron (GERN) Stock?", "Why Geron Stock Dropped 44% in 2018", "Geron Names CEO John Scarlett As Chairman, Succeeding Hoyoung Huh", "Here Are Biotech\u2019s Big Pipeline Disappointments in 2018", "Top 10 Healthcare Stories of 2018", "Health Care Sector Update for 12/04/2018: GERN,CLVS,PSTI", "Could Geron Be a Millionaire-Maker Stock?", "How Geron's Horrible Year Is a Great Reminder to Investors", "Geron's (GERN) Q3 Earnings Beat, Revenues Miss, Shares Down", "Geron (GERN) Reports Q3 Loss, Misses Revenue Estimates", "Scary Markets, Frightening Stocks, and How to Keep From Panicking", "Why Geron Corporation Stock Is Ripping Higher Today", "Geron (GERN) Stock Moves -0.58%: What You Should Know", "Here's Why Geron Plummeted 69% in September", "Geron (GERN) Down 13% Since Last Earnings Report: Can It Rebound?", "Are These Beaten-Down Clinical-Stage Biotech Stocks Buys?", "Geron Stock: Buy, Sell, or Hold?", "Biotech Stock Roundup: ALXN on Acquisition Spree, FDA Nod for REGN, AMGN Drugs", "2 Stocks That Could Benefit Big From Geron's Stumble", "Mid-Day Market Update: Crude Oil Up 1.5%; Altimmune Shares Plunge", "Why Geron Corporation's Stock Is Sinking, Again", "Mid-Morning Market Update: Markets Edge Lower; BlackBerry Earnings Beat Expectations", "Do Options Traders Know Something About Geron (GERN) Stock We Don't?", "Can Geron Corporation Recover From Its Breakup With Johnson & Johnson?", "After Its Disastrous Day, What's Next for Geron Corp.?", "Pre-Market Most Active for Sep 28, 2018 : TSLA, GERN, FCAU, TLRY, QQQ, VALE, TVIX, DTEA, DB, BAC, NOK, LYG", "Better Buy: Geron Corporation vs. Incyte Corporation", "Mid-Afternoon Market Update: Progress Software Falls Following Mixed Q3 Results; ChemoCentryx Shares Climb", "Mid-Day Market Update: Dow Rises Over 100 Points; Geron Shares Plunge", "Mid-Morning Market Update: Markets Open Higher; Conagra Misses Q1 Views", "Geron's Stock Plunges as J&J Ends Imetelstat Collaboration", "Pre-Market Most Active for Sep 27, 2018 : GERN, BBBY, UNM, GRPN, LONE, SKX, AAPL, MU, BJ, FCX, ARNC, CCJ", "US Futures Point North After Fed Rate Hike; Data in Focus", "Why Geron Corporation's Stock Is Getting Hammered Today", "Why Bed Bath & Beyond, Geron, and Canopy Growth Slumped Today", "5 Top Stock Trades for Friday \u2014 BBBY, RAD and NFLX", "Mid-Afternoon Market Update: Bed Bath & Beyond Drops Following Weak Q2 Results; Cameco Shares Surge", "Health Care Sector Update for 09/27/2018: WCG, AET, CVS, GWPH, GERN, JNJ", "Wall Street Set For Gains After Fed Rate Hike, Q2 GDP Growth Steady at 4.2%", "7 Biotech Stocks to Buy Now", "Options Traders Expect Huge Moves in Geron (GERN) Stock", "Geron Corp: Lost in Translation?", "Geron Corporation: A Sober Assessment", "Noteworthy Tuesday Option Activity: TXN, GERN, V", "3 Biotech Stocks That Still Have Major Catalysts in September", "3 Top Stocks Under $10", "Why Geron Corporation Stock Is Bolting Higher Today", "7 Biotech Stocks to Buy Now", "Options Traders Expect Huge Moves in Geron (GERN) Stock", "Geron Corp: Lost in Translation?", "Why Geron Corporation's Stock Is Charging Higher Today", "Johnson & Johnson Is Hiring -- and It's Ginormous News for Geron", "Why Yum China Holdings, Brooks Automation, and Geron Jumped Today", "Has Geron Corporation's Stock Been De-Risked?", "Geron Stock Up More Than 200% in 2018 So Far: Here's Why", "Noteworthy Monday Option Activity: GERN, FIT, FTV", "Mid-Day Update: Wall Street Higher as Powell Sticks to Rate Hike Course", "Geron Corporation Stock Shoots Up on Job Posting News", "Noteworthy Friday Option Activity: XLRN, GERN, CAL", "Better Speculative Biotech Stock: Amarin Corporation vs. Geron Corporation", "Implied Volatility Surging for Geron (GERN) Stock Options", "3 Reasons Geron Corporation Stock Could Be a Big Winner", "Pre-Market Most Active for Aug 27, 2018 : CRON, TSLA, TLRY, CGC, AKS, GERN, TKC, BABA, QQQ, NFLX, QD, TEVA", "Noteworthy Monday Option Activity: GERN, FIT, FTV", "Mid-Day Update: Wall Street Higher as Powell Sticks to Rate Hike Course", "Geron Corporation Stock Shoots Up on Job Posting News", "Noteworthy Friday Option Activity: XLRN, GERN, CAL", "Why Geron Corporation Stock Is Heading Higher Today", "After Hours Most Active for Jun 15, 2018 : ENDP, RRC, HFC, BR, GERN, QQQ, AAPL, BAC, CSCO, OPK, GE, WFC", "Notable Friday Option Activity: XOM, GERN, PFE", "Geron (GERN) Q2 Loss In Line, Revenues Up Y/Y, Shares Down", "3 Likely Reasons Geron Stock Is Sizzling Hot Right Now", "What Is Geron Corporation's Downside Risk?", "Why Geron Corporation Stock Is Heating Up", "A Huge Decision Is on Tap for This Little Biotech Stock", "Implied Volatility Surging for Geron (GERN) Stock Options", "Is Geron (GERN) Outperforming Other Medical Stocks This Year?", "Geron (GERN) Q1 Loss Narrows Y/Y, Revenues Fall, Shares Down", "These 3 Stocks Shot Up 50% in 2017 -- Are They Still Buys?", "Health Care Sector Update for 05/11/2018: SBOT,SUPN,AKCA,GERN", "Health Care Sector Update for 05/11/2018: GERN,SBOT", "Why Geron Corporation Stock Sank Last Month", "What's in the Cards for Geron (GERN) This Earnings Season?", "Is Geron Corporation (GERN) Stock Outpacing Its Medical Peers This Year?", "Geron Corporation: The Clock Is Ticking", "Pre-Market Most Active for Apr 17, 2018 : NFLX, TVIX, SQQQ, QQQ, GS, RIO, TWTR, BAC, BABA, CHK, GERN, ROKU", "Health Care Sector Update for 05/11/2018: SBOT, AZN, GERN", "Here's Why Geron Stock Surged More Than 90% in 6 Months", "Pre-Market Most Active for Apr 13, 2018 : BAC, TVIX, HDB, JPM, MFGP, C, CHL, MU, GERN, DBX, QQQ, NFLX", "Why Geron Corporation Stock Popped 84% in March", "Why Geron Corporation Stock Is on the Rise Today", "Thursday Sector Leaders: Biotechnology, Railroads", "3 Reasons This Clinical-Stage Biotech Is an Incredible Bargain", "Why Geron Corporation's Stock Is Heading Higher Today", "Are Short-Sellers Right About Geron Corporation?", "These 3 Biotech Stocks Are Soaring, but Are They Buys Now?", "Incyte Could Have a Problem (or 2!) on Its Hands", "Geron Corp. Skyrocketed and AbbVie Inc. Crashed -- Are These Stocks Buys?", "Here's Why Geron's Stock Is Cratering Today", "Why Geron Corporation Stock Is Crashing Today", "Pre-Market Most Active for Mar 27, 2018 : QQQ, FB, GE, MU, TVIX, GERN, USLV, GSK, BAC, BABA, DB, RIO", "Why Geron Corporation Stock Is Falling Today", "3 Biotech Stocks That Skyrocketed This Week: Are They Buys?", "Why Geron Corp. Is Rallying 10% Today", "Is Geron Corporation Stock Still a Strong Buy?", "Why Geron Corporation Stock Is Up Big Again Today", "Here's Why Geron Corporation Stock Popped Today", "Mid-Day Market Update: Dow Falls Over 300 Points; Klondex Mines Shares Spike Higher", "Geron (GERN) Q4 Loss Flat Y/Y, Revenues Surge, Shares Up", "Why Twitter, Overstock.com, and Geron Slumped Today", "Health Care Sector Update for 03/19/2018: MDWD, REGN, CDTX, GERN", "Pre-Market Most Active for Mar 19, 2018 : FB, QQQ, MU, TVIX, MFGP, CSRA, GERN, SQQQ, SBGL, NOK, BABA, DB", "Geron (GERN) Q4 2017 Earnings Conference Call Transcript", "Why Canadian Solar, Geron, and NovaGold Resources Jumped Today", "Health Care Sector Update for 03/19/2018: CDTX,MDWD,GERN,REGN", "Mid-Afternoon Market Update: NASDAQ Slides Over 2.5%; Micro Focus Shares Plummet", "Health Care Sector Update for 03/19/2018: MDWD,GERN,REGN", "Mid-Morning Market Update: Markets Open Lower; KLA-Tencor To Buy Orbotech", "Geron (GERN) in Focus: Stock Moves 10.8% Higher", "J&J's (JNJ) Erdafitinib Gets Breakthrough Therapy Status", "After-Hours Earnings Report for March 16, 2018 : GERN, ATEN", "Mid-Day Market Update: Dow Rises Over 200 Points; Invuity Shares Plummet", "Here's Why Shorting Geron Corporation Stock Is a Terrible Idea", "Mid-Afternoon Market Update: Image Sensing Systems Gains Following Q4 Results; J.Jill Shares Plummet", "Why Geron Corporation Stock Is Rising Today", "Is Geron Corporation's Stock Set to Sail or Sink?", "What's in the Cards for Geron (GERN) This Earnings Season?", "5 Risky, But Rewarding, Ways to Play the Rebound", "Why Geron Corporation Stock Ripped Higher in January", "3 Biotech Stocks That Soared This Week: Are They Buys?", "Mid-Afternoon Market Update: Crude Oil Down 1.5%; Natural Grocers Shares Drop On Earnings Miss", "Geron Stock Is Heating Up. Time to Buy?", "Monday's ETF Movers: XBI, GDXJ", "3 Top Biotech Stocks to Buy in March", "Geron Corporation's 13% Drop in 2017, Explained", "3 Stocks That Feel Like Microsoft in 1986", "5 Biotech Buyout Candidates for 2018", "3 Top Healthcare Stocks to Buy in December", "Paratek Pharmaceuticals Set To Explode As The Holy Grail Of Antibiotics Omadacycline Nears FDA Approval", "3 Stocks to Hold for the Next 20 Years", "2 Reasons Geron Corporation Took a Pounding in November", "3 Stocks That Feel Like Disney in 1957", "Geron Corporation's 13% Drop in 2017, Explained", "3 Stocks That Feel Like Microsoft in 1986", "5 Biotech Buyout Candidates for 2018", "Pre-Market Most Active for Oct 31, 2017 : UA, UAA, INTC, MU, TEVA, AAPL, SHOP, QCOM, GERN, LL, BABA, MDLZ", "3 Stocks With Microsoft-like Return Potential", "What's in the Cards for Geron (GERN) this Earnings Season?", "The Smartest Move Johnson & Johnson Has Made All Year", "1 High-Risk Penny Stock That May Be Worth Buying", "Geron (GERN) Q3 Loss Narrower Than Expected, Sales Miss", "Geron's (GERN) Imetelstat Progressing Well, Setbacks Concern", "Geron (GERN) Q2 Loss Narrows, Sales Miss Estimates, Stock Up", "Johnson & Johnson's 3 Biggest Sources of Growth Over the Next 10 Years", "Mid-Day Market Update: Pitney Bowes Drops On Earnings Miss; Lumber Liquidators Shares Climb", "Why Pitney Bowes, Geron, and Cummins Slumped Today", "The Key Reason Incyte Corporation Added $850 Million in Market Cap in August", "3 Top Stocks Under $5", "3 Top Biotech Stocks Under $5", "3 Healthcare Stocks for Ambitious Investors", "3 Stocks Billionaires Can't Buy, but You Can", "Here's Why Johnson & Johnson Is Valued at Its Highest P/E in a Decade", "Why Geron (GERN) Might Be a Diamond in the Rough", "Geron Stock Up Almost 40% So Far This Year After '16 Decline", "Here's Why Geron Corporation Fell as Much as 16.6% Today", "Here's Why Geron (GERN) is a Good Stock to Invest in Now", "The Zacks Analyst Blog Highlights: Cambrex, Geron, Anavex Life Sciences and Histogenics", "Fresh Capital to Be Injected into Biotech Stocks: 5 Must-Buys", "3 Hiddem Gems in the Healthcare Sector", "Omeros (OMER) Hits New 52-Week High on Positive FDA Decision", "Mallinckrodt Initiates Amyotrophic Lateral Sclerosis Study", "Geron (GERN) Up 3.1% Since Earnings Report: Can It Continue?", "5 Biomedical Stocks That Are Expected To Surge", "Johnson & Johnson's Analyst Day Was Overshadowed by This Worrisome Data", "These 3 Biotech Stocks Have Ballooned in 2017, but Will They Pop?", "Geron Corp (GERN) Worth a Look: Stock Adds 7% in Session", "Geron (GERN) Q1 Loss In Line, Focus Remains on Imetelstat", "3 Biotech Stocks Projected to Grow Their EPS by at Least 415% in 2018", "Johnson & Johnson's 5% Dividend Increase Offers a Big Clue About Its Future", "This Major Catalyst Sent Geron Corporation Shares Higher by 13% in April", "3 Stocks With Zillow-Like Return Potential", "Will Geron (GERN) Continue to Surge Higher?", "This $26 Billion Company Is the Market's Most Overpriced Biotech Stock", "Top Ranked Momentum Stocks to Buy for April 18th", "3 Stocks Ripe for a Buyout", "Biotech Stock Roundup: Geron Gains on Interim Data, OncoMed Slumps on Pipeline Setback", "Geron Stock Rises after Positive Interim Update on Imetelstat", "Why Geron Corporation Stock Is Surging Higher Today", "Geron (GERN) Q1 Earnings: What's in Store for the Stock?", "Will Geron (GERN) Continue to Surge Higher?", "This $26 Billion Company Is the Market's Most Overpriced Biotech Stock", "Top Ranked Momentum Stocks to Buy for April 18th", "3 Stocks Ripe for a Buyout", "Biotech Stock Roundup: Geron Gains on Interim Data, OncoMed Slumps on Pipeline Setback", "Geron Stock Rises after Positive Interim Update on Imetelstat", "Why Geron Corporation Stock Is Surging Higher Today", "Geron (GERN) Q1 Earnings: What's in Store for the Stock?", "Why Knight Transportation, Geron, and Rent-A-Center Jumped Today", "4 Biotech Stocks With Jaw-Dropping Growth Potential", "Geron (GERN) Q4 Loss Narrows; Focus Remains on Imetelstat", "Drug Stocks Q4 Earnings Lineup for Mar 1: MYL, KERX & More", "Friday's ETF Movers: XBI, GDXJ", "3 Reasons Geron Corporation Plunged 57% in 2016", "4 Biotech Stocks to Buy in January", "4 Stocks Under $4 That Could Double", "Forget Anavex Life Sciences Corp.: These 2 Biotech Stocks Are Better Buys", "3 Beaten-Up Biotech Stocks: Are They Bargains?", "4 Small-Cap Stocks Worth Buying in 2017", "Penny Stocks: 2 to Buy, 2 to Avoid", "Intercept (ICPT) Q3 Loss Narrower than Expected, Sales Miss", "Aegerion (AEGR) Reports Narrower-than-Expected Loss in Q3", "3 Stocks Under $10 to Buy in 2017", "Alkermes (ALKS) Q3 Loss in Line, Sales Miss; '16 View Intact", "AmerisourceBergen (ABC) Q4 Earnings Top, Revenues Lag", "Gilead (GILD) Misses Q3 Earnings Estimates, Retains View", "The Waiting Game Sends Geron Corporation Lower by Another 18% in October", "Zoetis (ZTS) Tops Q3 Earnings Estimates, Updates Outlook", "Shire (SHPG) Misses Q3 Earnings & Revenue Estimates", "Here Are Johnson & Johnson's Next 10 Potential Blockbuster Drugs", "Geron (GERN) Reports Narrower-than-Expected Loss in Q3", "Geron (GERN) Q3 Earnings: Will the Store Pull a Surprise?", "Sarepta Therapeutics (SRPT) Incurs Narrower Y/Y Loss in Q3", "Acorda (ACOR) Reports Wider Q3 Loss, Revenues Down Y/Y", "Glaxo (GSK) Beats Q3 Earnings Estimates, Keeps 2016 View", "Alexion (ALXN) Q3 Earnings Lag, Revenues Tops; Lifts View", "Novartis (NVS) Tops Q3 Earnings, Misses Sales Estimates", "Amgen's (AMGN) Xgeva Meets Endpoint in Phase III Study", "3 Biotech Stocks That Could Double in 12 Months", "Merck's Antiviral Medicine Meets Endpoint in Phase III", "Top-Rated Stock Picks and Popular Stories on Nasdaq.com: October 9 - 15", "Regeneron & Teva Hit by Clinical Hold on Chronic Pain Study", "PTC Therapeutics Falls on FDA Denial of DMD Drug Appeal", "Shire (SHPG) Updates Vyvanse Label with New Efficacy Data", "Intercept (ICPT) Ocaliva Wins Positive CHMP Opinion for PBC", "Roche's Lucentis Prefilled Syringe Approved in the U.S.", "Roche (RHHBY) Misses Q3 Sales Estimates, 2016 View Intact", "Bristol-Myers Wins CHMP Nod for Opdivo Label Expansion", "Ocular's (OCUL) Stock Jumps on Collaboration with Regeneron", "Merck KGaA Offers Portfolio Updates at Market Day Event", "Celgene/Agios Ink Deals with Abbott to Identify IDH Mutations", "Merrimack's Onivyde Positive in Pancreatic Cancer Study", "Alnylam (ALNY) to Continue Phase III Study on Patisiran", "Mylan Up on EpiPen Medicaid Settlement, Cuts 2016 Outlook", "Allergan (AGN) Gains Rights to RTGel from UroGen Pharma", "Alnylam (ALNY) Discontinues Phase III Study on Revusiran", "Abeona Therapeutics (ABEO) Surges: Stock Rises 11.3%", "3 Battered Biotechs That Could Turn Things Around", "Roche (RHHBY) Actemra Gets Breakthrough Therapy Status", "Bayer (BAYRY) Closes Registration Process for Kyleena in EU", "Theravance (TBPH) Starts Dosing in Ulcerative Colitis Study", "The Zacks Analyst Blog Highlights: VIVUS, Geron, Achillion Pharmaceuticals, Anika Therapeutics and ANI Pharmaceuticals", "Here's Why Geron Corporation Tumbled 16% in September", "Athersys (ATHX) Shows Strength: Stock Moves 5.1% Higher", "GW Pharma Attains 52-Week High on Positive Epidiolex Data", "Endo Appoints New CEO, Keeps Q3 & '16 View, Stock Jumps", "Chiasma (CHMA) Shows Strength: Stock Moves 5.9% Higher", "Biotech Stocks Under $5: 2 to Buy, 1 to Avoid", "Teva Reports Positive Phase III Tardive Dyskinesia Data", "3 Battered Biotechs That Could Turn Things Around", "Jazz Initiates Rolling NDA for Leukemia Candidate Vyxeos", "Biotech Stock Roundup: Tobira Soars on Acquisition Deal, FDA Says Yes to Sarepta DMD Drug", "Johnson & Johnson's Smart (Yet Surprising) Acquisition", "AveXis (AVXS) Shows Strength: Stock Adds 6.3% in Session", "Celgene Presents Efficacy & Safety Phase II Ozanimod Data", "Pfizer (PFE) Breast Cancer Drug Ibrance Wins CHMP Backing", "Amgen (AMGN) Parsabiv Gets Positive CHMP Opinion in EU", "Curis (CRIS) Shows Strength: Stock Adds 6.9% in Session", "Amgen (AMGN) Repatha Meets Endpoints in Phase III Study", "Biotech Stock Roundup: Tobira Soars on Acquisition Deal, FDA Says Yes to Sarepta DMD Drug", "FDA Panel Suggests Removing Warning from Pfizer's Chantix", "Glaxo (GSK) Publishes Phase III Data on Shingles Vaccine", "BeiGene (BGNE) Catches Eye: Stock Adds 6% in Session", "Spectrum (SPPI) Down, Qapzola Fails to Impress FDA Panel", "Sarepta Shares Soar on News of Key Drug Critic FDA Exit", "Ligand (LGND) Commences Phase II Type II Diabetes Study", "Novavax Tanks, RSV F Vaccine Disappoints in Two Studies", "bluebird bio (BLUE) in Focus: Stock Moves 11.4% Higher", "FDA Panel Suggests Removing Warning from Pfizer's Chantix", "Glaxo (GSK) Publishes Phase III Data on Shingles Vaccine", "Horizon (HZNP) to Acquire Raptor for $800M, Stock Soars", "Why Geron Corporation Is Plunging Today", "Mid-Day Market Update: American Farmland Gains Following Merger News; RetailMeNot Shares Drop", "Lexicon Hits 52-Week High on Positive Type I Diabetes Data", "Biotech Stock Roundup: Horizon-Raptor Acquisition Deal, Geron Down on Pipeline News", "Geron (GERN) at 52-Week Low on Imetelstat Study Update", "J&J Files for Single-Tablet Regimen of HIV Drug Prezista in EU", "Perrigo Up as Starboard Reveals Stake, Changes Proposed", "What Happened in the Stock Market Today", "Why Geron Corporation (GERN), Polaris Industries Inc. (PII) and VimpelCom Ltd (ADR) (VIP) Are 3 of Today\u2019s Worst Stocks", "Mid-Afternoon Market Update: Dow Surges Over 200 Points; Geron Shares Tumble", "Health Care Sector Update for 09/12/2016: GERN, JNJ, RPTP", "Mid-Morning Market Update: Markets Rise; Horizon Pharma To Buy Raptor Pharmaceutical For $9/Share", "Clovis' Rucaparib Not to Face FDA Advisory Panel, Stock Up", "2 Companies Johnson & Johnson Should Consider Buying", "Clovis Oncology (CLVS) in Focus: Stock Moves 15% Higher", "Can the Rally in Geron (GERN) Shares Continue?", "Agios' (AGIO) Partner Celgene to File for Enasidenib, Stock Up", "Ligand/Retrophin Rare Disease Drug Positive in Phase II", "Bristol-Myers' Orencia Gains EU Approval for Expanded Use", "3 All-or-Nothing Biotechs I'm Watching Like a Hawk", "Astrazeneca (AZN) Presents Benralizumab Phase III Data", "Merck Stops Development of Odanacatib for Osteoporosis", "Mylan (MYL) Gets Positive Copaxone USPTO Ruling Yet Again", "Amgen Gets FDA Approval for Label Expansion of Blincyto", "3 Statistics That Should Get Johnson & Johnson's Long-Term Shareholders Very Excited", "Allergan, Adamas Agree to Settle Namzaric Patent Litigation", "Pfizer's Lung Cancer Drug Xalkori Label Expanded in the EU", "BioMarin's (BMRN) Brineura Review Period Extended by FDA", "Inovio Stock Up as Second Zika Virus Vaccine Study Begins", "Mylan (MYL) Obtains Favorable USPTO Ruling for Copaxone", "Momenta Pharmaceuticals (MNTA) Jumps: Stock Up 11.3%", "Clovis (CLVS) Stock Up on FDA Priority Review for Rucaparib", "Gilead (GILD) Truvada Gets EU Approval for Label Expansion", "Regeneron Stock Up on BARDA Deal for MERS Antibodies", "ARIAD Finishes Rolling NDA for Lung Cancer Drug Brigatinib", "Alexion's GVHD Candidate Gets Orphan Drug Status in the EU", "Inovio Stock Up as Second Zika Virus Vaccine Study Begins", "Mylan (MYL) Obtains Favorable USPTO Ruling for Copaxone", "Portola (PTLA) Stock Down on CRL for AndexXa BLA in U.S.", "Intercept (ICPT) Ocaliva Phase III POISE Data Published", "Anthera Pharmaceuticals (ANTH) Jumps: Stock Rises 7.9%", "Alder Biopharmaceuticals (ALDR) Jumps: Stock Rises 9.6%", "Radius (RDUS) Osteoporosis Drug Positive in Phase III Study", "J&J's (JNJ) Depression Treatment Esketamine Gets BTD", "Repros Presents 6-Month Interim Data on Enclomiphene", "UCB Epilepsy Drug Vimpat's Patent Validated by U.S. Court", "Vertex (VRTX) To Stop VX-661-Ivacaftor Study, Stock Down", "Dicerna Pharmaceuticals (DRNA) Jumps: Stock Rises 7.5%", "BioDelivery (BDSI) Q2 Loss Meets Estimates, Revenues Up", "Inovio (INO) Veterinary Vaccine Rights Licensed to Plumbline", "Mylan Beats on Q2 Earnings, Revenues Miss, Keeps '16 View", "Repros (RPRX) Q2 Loss Narrower Y/Y, Focus on Pipeline", "Ionis (IONS) Q2 Loss Narrower than Expected, Issues Outlook", "Aegerion (AEGR) Q2 Loss Wider than Expected, View Intact", "GW Pharma (GWPH) Incurs Narrower-than-Expected Q3 Loss", "Endo (ENDP) Tops Q2 Earnings Estimates, Keeps 2016 View", "Epizyme (EPZM) Q2 Loss Lower than Expected, Costs to Rise", "Puma (PBYI) Posts Narrower Loss in Q2, Focus on Neratinib", "Mylan Beats on Q2 Earnings, Revenues Miss, Keeps '16 View", "Repros (RPRX) Q2 Loss Narrower Y/Y, Focus on Pipeline", "Ionis (IONS) Q2 Loss Narrower than Expected, Issues Outlook", "BioMarin (BMRN) Posts Narrower Q2 Loss, Sales View Upped", "Agios (AGIO) Q2 Loss Wider than Expected, Pipeline in Focus", "AVEO (AVEO) Reports a Wider Loss in Q2, Tivozanib in Focus", "Endocyte (ECYT) Reports Narrower-than-Expected Loss in Q2", "Endocyte (ECYT) Q2 Loss Wider than Expected (Revised)", "Juno (JUNO) Q2 Loss Wider-than-Expected, Focus on Pipeline", "Teva (TEVA) Beats on Q2 Earnings & Revenues, Stock Gains", "Ligand (LGND) Q2 Earnings Decline Y/Y, Maintains View", "ImmunoGen (IMGN) Reports Wider-than-Expected Loss in Q4", "Geron (GERN) Posts Narrower-Than-Expected Loss in Q2", "4 Top Stocks Under $5", "Drug Stocks to Watch for Earnings on Aug 3: ZTS, EXEL & More", "Radius Health (RDUS) Reports Wider-than-Expected Q2 Loss", "Juno (JUNO) Q2 Loss Wider-than-Expected, Focus on Pipeline", "Teva (TEVA) Beats on Q2 Earnings & Revenues, Stock Gains", "Ligand (LGND) Q2 Earnings Decline Y/Y, Maintains View", "ImmunoGen (IMGN) Reports Wider-than-Expected Loss in Q4", "Geron (GERN) Posts Narrower-Than-Expected Loss in Q2", "9 Easy Ways to Lose Money in the Stock Market", "4 Catalysts Send Incyte Corporation 17% Higher in May", "Geron (GERN) Q2 Earnings: What's in Store for the Stock?", "Geron (GERN) Q1 Loss In-Line, Imetelstat Remains in Focus", "Drug Stocks Earnings Preview: GERN, RPRX, ICPT, AGIO & More", "Geron (GERN) Q1 Earnings: What's in Store for the Stock?", "Are These 3 Biotechs Destined to Be Bought Out?", "3 Likely Reasons Why Geron Corporation Vaulted Higher By 18% in March", "These 4 Healthcare Stocks Are All Soaring Today, and Here's Why", "Buying These 2 Drug Developers Would Make a Lot of Sense for Johnson & Johnson", "These Growth Stocks Could Double Over the Next 12 Months", "4 Surging Stocks Brokers Love in the Healthcare Sector", "Gilead and 4 Other Buy Stocks in the Biotech Industry", "3 Biotech Stocks to Buy on Sale", "3 Stocks That Could Make You Rich", "3 Reasons Geron Corporation Stock Could Rise", "Geron Q4 Loss In-Line with Estimates, Imetelstat in Focus", "Geron (GERN) to Report Q4 Earnings: What's in Store?", "The Zacks Analyst Blog Highlights: Corcept Therapeutics, Epizyme, Geron and Synthetic Biologics", "Why Incyte's Shares Are Tumbling Today", "Why Shares of Geron Corp. Cratered in January", "Shares of Incyte Corporation Plummeted in January -- Here's Why", "2 Beaten-Down Biotech Stocks to Buy in February", "2 Speculative Small-Cap Biotech Stocks That Could Double", "Geron Up, Myelodysplastic Syndromes Phase II/III Study Begins", "Johnson & Johnson's CEO Just Tipped His Cap in a Big Way Regarding M&A", "3 All-or-Nothing Biotech Stocks We're Closely Watching", "Why Incyte's Shares Are Tumbling Today", "Why Shares of Geron Corp. Cratered in January", "3 Biotech Stocks Under $5 That Could Explode Higher in 2016", "Will Johnson & Johnson Raise Its Dividend in 2016?", "November's Best Healthcare ETF", "The Potential for New Data Lifts Geron Corporation in November", "Geron Corporation Exploded 49% Higher in 2015 -- Here's Why", "Noteworthy Monday Option Activity: GERN, VRA, CIT", "Time Provides the Best Cure for Geron's Recent Weakness", "Geron Beats on Q3 Earnings & Revenues, Imetelstat in Focus", "Will Geron (GERN) Post a Wider-than-Expected Loss in Q3?", "Can the Rally in Geron (GERN) Shares Continue?", "Unknown Small-Cap Stocks That Should Be on Your Radar", "Should Geron Corporation (GERN) Be On Your Radar Now?", "Will Geron (GERN) Continue to Surge Higher?", "Health Care Sector Update for 09/16/2015: BMY, AGN, GERN", "This Small-Cap Biotech Could Wind Up Devouring a Much Larger Foe's Revenue Stream", "The Zacks Analyst Blog Highlights: Amgen, Tetraphase, Geron, Alexion and ACADIA", "Biotech Stock Roundup: Biosimilar Competition for Amgen, Tetraphase Hit By Disappointing Data", "Here's Why Geron Corporation's Stock Is Ripping Higher Today", "US Stock Futures Extend Gains as Jobless Claims Rise More Than Expected", "Pre-Market Most Active for Sep 3, 2015 : GERN, XIV, BP, BAC, AAPL, NOK, QQQ, TVIX, FB, BHP, SUNE, NVS", "Can Geron (GERN) Run Higher on Strong Earnings Estimate Revisions?", "Health Care Sector Update for 09/16/2015: BMY, AGN, GERN", "This Small-Cap Biotech Could Wind Up Devouring a Much Larger Foe's Revenue Stream", "The Zacks Analyst Blog Highlights: Amgen, Tetraphase, Geron, Alexion and ACADIA", "3 Experimental Cancer Drugs Investors Should Be Closely Watching", "This Biotech Stock Has Jaw-Dropping Growth Potential", "Can the Rally in Geron (GERN) Shares Continue? - Tale of the Tape", "US Stock Futures Modestly Higher as ECB Leaves Rates Unchanged; Weekly Jobless Data on Tap", "Geron Q1 Loss In Line with Estimates, Restructuring on Track - Analyst Blog", "Health Care Sector Update for 05/01/2015: GERN,NKTR,TLOG", "The Zacks Analyst Blog Highlights: Gilead Sciences, Biogen, Geron, Johnson & Johnson and Anthera Pharmaceuticals - Press Releases", "Forget Gilead (GILD), Buy These Impressive Biotech Stocks Instead - Analyst Blog", "Health Care Sector Update for 04/21/2015: GERN, MYL, TEVA, NVGN, JNJ", "3 Biotech Stocks Under $10 with Amazing Growth Prospects - Analyst Blog", "The Reason Behind Geron Corporation's 25% Catapult Higher in March", "Why Geron (GERN) Might Be a Diamond in the Rough - Tale of the Tape", "Geron Q1 Loss In Line with Estimates, Restructuring on Track - Analyst Blog", "Health Care Sector Update for 05/01/2015: GERN,NKTR,TLOG", "What's in Store for Geron (GERN) this Earnings Season? - Analyst Blog", "3 All-or-Nothing Biotech Stocks We're Closely Watching", "The Small-Cap Stock I'm Watching in 2015", "3 Biotech Stocks That Could Double in 2015", "Market Has Not Yet Noticed Potential in Geron (GERN); Have You? - Tale of the Tape", "Why Geron Corporation (GERN) Stock Might be a Great Pick - Tale of the Tape", "Geron (GERN) Stock: Moving Average Crossover Alert - Tale of the Tape", "Health Care Sector Update for 12/05/2014: GERN,ATOS,PBMD", "Why Geron Corporation Stock Surged 65% in November", "3 Biotech Stocks With Jaw-Dropping Growth Potential in 2015", "3 Healthcare Stocks Short-Sellers Are Wrong About", "Biotech Stock Roundup: Geron Soars on $935M J&J Deal, Gilead's Harvoni Approved in the EU - Analyst Blog", "Market Has Not Yet Noticed Potential in Geron (GERN); Have You? - Tale of the Tape", "Geron Collaborates with J&J for Imetelstat - Analyst Blog", "Health Care Sector Update for 11/14/2014: GERN,JNJ,IMUC,VASC", "Biotech Stock Roundup: Regeneron's Eylea Stumbles, Geron Up on Lifting of Clinical Hold - Analyst Blog", "Mid-Morning Market Update: Markets Mixed; Publicis To Acquire Sapient For $3.7 Billion", "Why Geron Corporation Shares Skyrocketed", "Pre-Market Most Active for Nov 3, 2014 : SAPE, ARCP, GERN, SAP, WAC, NOK, UN, FB, BABA, PBR, TVIX, AAPL", "Mid-Day Market Update: Ford Falls On October Sales Report; Geron Shares Climb", "Can the Rally in Geron (GERN) Shares Continue? - Tale of the Tape", "The Next Industry Google Plans to Transform", "Why Geron Corporation Stock Is Down a Shocking 52% in 2014", "Why You Shouldn't Bet Against Geron Corporation (GERN) Stock - Tale of the Tape", "Geron Corp. (GERN) Jumps: Stock Moves 8.1% Higher - Tale of the Tape", "Geron (GERN) Enters Overbought Territory - Tale of the Tape", "Geron (GERN) Falls: Stock Goes Down 5.4% - Tale of the Tape", "Geron Gains as FDA Lifts Partial Hold on Imetelstat Study - Analyst Blog", "Is Sarepta Therapeutics Inc. Stock a Short Sell?", "US Futures Point to Lower Open as Data Disappoint; Global Growth Forecast Cut", "Sector Update: Healthcare Shares Flat Pre-Market; Geron Gets Partial Clinical Hold Lifted", "Sector Update: Healthcare", "US Stock Futures Slip on Weak Jobless Numbers, Retail Figures, World Bank Lowering Global Forecast", "Pre-Market Most Active for Jun 12, 2014 : EXC, LULU, GERN, FB, BAC, APU, BHP, RIO, ACHN, AAPL, LYG, TVIX", "Biotech ETFs Bounce Back After Three-Month Correction", "Mid-Day Market Update: Rackspace Gains On Upbeat Earnings; DXP Enterprises Shares Slip", "Geron Corp. (GERN) Soars: Stock Up 10.6% - Tale of the Tape", "US Futures Point to Lower Open as Data Disappoint; Global Growth Forecast Cut", "Sector Update: Healthcare Shares Flat Pre-Market; Geron Gets Partial Clinical Hold Lifted", "Sector Update: Healthcare", "After-Hours Earnings Report for March 25, 2014 : PVH, FIVE, SCS, GERN, LNDC, GOL, EXFO, AXU, HTM, GEVO, CYCC, WLDN", "Tuesday's ETF Movers: GDXJ, XBI", "Pre-Market Most Active for Mar 19, 2014 : VZ, RDS/A, HZNP, ORCL, QQQ, NOK, SNY, FCEL, KNDI, GERN, SIRI, BP", "Mid-Afternoon Market Update: Markets Trade In Choppy Session As Elizabeth Arden Shares Remain Down", "Geron Reports In-Line Q1 Loss - Analyst Blog", "Mid-Afternoon Market Update: Markets Mixed as Geron Shares Take a Beating Following FDA Release", "Healthcare Stocks Slipping Ahead of Closing Bell; Geron Tumbles After FDA Shelves Work on Blood-Disorder Treatment", "Sector Update: Healthcare", "After-Hours Earnings Report for March 12, 2014 : WSM, MTN, HMIN, MTDR, KKD, SGMS, IRET, DEPO, NSU, OREX, GERN, EOX", "Use Options For a Chance To Buy GERN at a 52% Discount", "Clinical Trial Hold Of Geron's Revolutionary Drug Imetelstat Will Be Temporary", "Tuesday's ETF Movers: XBI, GDXJ", "Geron Plunges on FDA Clinical Hold - Analyst Blog", "Mid-Afternoon Market Update: Markets Post Rally to Go Into the Green; Precious Metals Take a Hit", "Healthcare Stocks Slightly Lower; Geron Sinks After Researcher Ends Patient Enrollment", "Sector Update: Healthcare", "Geron Corporation (GERN): New Analyst Report from Zacks Equity Research - Zacks Equity Research Report", "Strength Seen in Geron Corporation (GERN): Stock Surges 23.6% - Tale of the Tape", "Mid-Morning Market Update: Markets Edge Lower; Toll Brothers Profit Tops Estimates", "Pre-Market Most Active for Dec 10, 2013 : NOK, ASX, GERN, AALCP, ARCC, SMFG, ARIA, NJ, BAC, ALU, MU, BRCM", "Stocks Pressured Lower, Dow Closes Below 16,000", "Sector Update: Healthcare Stocks Higher; Ziopharm Climbs 5% on Approval for Study of Brain Cancer", "Sector Update: Healthcare", "Pre-Market Most Active for Dec 6, 2013 : QQQ, BAC, NOK, INTC, GERN, JCP, ALU, FB, RAD, DOC, XIV, DRYS", "Largest option trades in equities", "Is Geron Corporation (GERN) Stock a Solid Choice Right Now? - Tale of the Tape", "Healthcare Stocks Near Session Bests; Geron Pops to New 52-Week High After New Coverage at MLV & Co.", "Sector Update: Healthcare", "Narrower Q2 Loss at Geron - Analyst Blog", "Neuralstem: Anticipating More Efficacy Data From ALS Trial And Update On New Clinical Trials", "Geron Narrows Loss; Cuts Jobs - Analyst Blog", "Weekly CEO Buys Highlight: IBTX, INSM, GERN, INO, EQU", "Lower Loss at Geron - Analyst Blog", "Geron Q3 Loss in Line; Shares Up on ASH Abstract - Analyst Blog", "Healthcare Stocks Near Session Bests; Geron Pops to New 52-Week High After New Coverage at MLV & Co.", "Sector Update: Healthcare", "Narrower Q2 Loss at Geron - Analyst Blog", "Geron Posts Narrower Loss - Analyst Blog", "Geron Hit by Pipeline Setback - Analyst Blog", "Buy or Sell? Monday's Losers: TITN, GERN", "Geron Posts In-Line Loss - Analyst Blog", "After-Hours Earnings Report for March 12, 2013 : KW, DOLE, ACAD, GCA, GNMK, AVID, WSR, KTOS, GERN, ACRX, FOLD, GCAP", "Neutral on Geron Corp. - Analyst Blog", "Geron Misses Estimates - Analyst Blog", "Stem Cell Therapy May Prevent Heart Failure: 4 Companies to Watch", "Medical Breakthrough: Successful Stem Cell Transplant in Sweden", "8 Cash-Comfortable Stocks Under $5", "Stocks Shed Early Upside at Mid-Day; Investors Eye Bernanke Testimony, Oil Price Spike", "Mid-Day Update: Stocks Sinking Despite Positive Supply Data; Bernanke Talks Inflation", "Geron Narrows Loss on Lower Costs - Analyst Blog", "Geron: Buyer Beware", "Joe Feshbach's Highest Conviction Position: A Regenerative Medicine 'Game Changer'", "Momentum Ideas: 15 Undervalued Stocks Approaching An Inflection Point"], "Elapsed Time": ["MAY 29, 2020", "MAY 28, 2020", "MAY 28, 2020", "MAY 22, 2020", "MAY 15, 2020", "MAY 14, 2020", "APR 8, 2020", "APR 2, 2020", "MAY 29, 2020", "MAR 13, 2020", "MAR 12, 2020", "MAR 12, 2020", "JAN 29, 2020", "JAN 22, 2020", "JAN 22, 2020", "JAN 7, 2020", "MAR 27, 2020", "NOV 6, 2019", "OCT 19, 2019", "OCT 11, 2019", "OCT 11, 2019", "OCT 11, 2019", "OCT 3, 2019", "OCT 1, 2019", "NOV 8, 2019", "OCT 1, 2019", "SEP 21, 2019", "AUG 6, 2019", "AUG 2, 2019", "JUL 8, 2019", "MAY 16, 2019", "APR 20, 2019", "OCT 1, 2019", "OCT 1, 2019", "SEP 21, 2019", "MAR 8, 2019", "MAR 7, 2019", "MAR 7, 2019", "MAR 5, 2019", "MAR 3, 2019", "MAR 14, 2019", "FEB 13, 2019", "FEB 6, 2019", "JAN 15, 2019", "DEC 31, 2018", "DEC 18, 2018", "DEC 13, 2018", "DEC 4, 2018", "FEB 23, 2019", "NOV 2, 2018", "NOV 2, 2018", "NOV 2, 2018", "NOV 1, 2018", "NOV 1, 2018", "OCT 10, 2018", "OCT 9, 2018", "DEC 1, 2018", "OCT 8, 2018", "OCT 8, 2018", "OCT 3, 2018", "SEP 29, 2018", "SEP 28, 2018", "SEP 28, 2018", "SEP 28, 2018", "OCT 9, 2018", "SEP 28, 2018", "SEP 28, 2018", "SEP 28, 2018", "SEP 28, 2018", "SEP 28, 2018", "SEP 27, 2018", "SEP 27, 2018", "SEP 28, 2018", "SEP 27, 2018", "SEP 27, 2018", "SEP 27, 2018", "SEP 27, 2018", "SEP 27, 2018", "SEP 27, 2018", "SEP 27, 2018", "SEP 27, 2018", "SEP 19, 2018", "SEP 13, 2018", "SEP 12, 2018", "SEP 11, 2018", "SEP 11, 2018", "SEP 5, 2018", "SEP 5, 2018", "SEP 24, 2018", "SEP 19, 2018", "SEP 13, 2018", "AUG 30, 2018", "AUG 28, 2018", "AUG 28, 2018", "AUG 28, 2018", "AUG 27, 2018", "SEP 4, 2018", "AUG 27, 2018", "AUG 24, 2018", "AUG 24, 2018", "AUG 17, 2018", "AUG 16, 2018", "AUG 13, 2018", "AUG 6, 2018", "AUG 27, 2018", "AUG 27, 2018", "AUG 24, 2018", "AUG 24, 2018", "JUL 6, 2018", "JUN 18, 2018", "JUN 15, 2018", "JUN 15, 2018", "AUG 1, 2018", "MAY 25, 2018", "MAY 25, 2018", "MAY 23, 2018", "MAY 16, 2018", "MAY 16, 2018", "MAY 14, 2018", "MAY 11, 2018", "MAY 29, 2018", "MAY 11, 2018", "MAY 11, 2018", "MAY 4, 2018", "MAY 3, 2018", "APR 25, 2018", "APR 23, 2018", "APR 17, 2018", "MAY 11, 2018", "APR 13, 2018", "APR 13, 2018", "APR 13, 2018", "APR 12, 2018", "APR 12, 2018", "APR 9, 2018", "APR 17, 2018", "APR 2, 2018", "MAR 29, 2018", "MAR 29, 2018", "MAR 29, 2018", "MAR 28, 2018", "MAR 27, 2018", "MAR 27, 2018", "APR 2, 2018", "MAR 24, 2018", "MAR 23, 2018", "MAR 22, 2018", "MAR 21, 2018", "MAR 19, 2018", "MAR 19, 2018", "MAR 19, 2018", "MAR 27, 2018", "MAR 19, 2018", "MAR 19, 2018", "MAR 19, 2018", "MAR 19, 2018", "MAR 19, 2018", "MAR 19, 2018", "MAR 19, 2018", "MAR 19, 2018", "MAR 16, 2018", "MAR 16, 2018", "MAR 16, 2018", "MAR 15, 2018", "MAR 15, 2018", "MAR 15, 2018", "MAR 13, 2018", "MAR 18, 2018", "FEB 20, 2018", "FEB 7, 2018", "FEB 4, 2018", "FEB 3, 2018", "FEB 2, 2018", "JAN 31, 2018", "JAN 29, 2018", "MAR 6, 2018", "JAN 9, 2018", "JAN 3, 2018", "DEC 13, 2017", "DEC 12, 2017", "DEC 12, 2017", "DEC 11, 2017", "DEC 6, 2017", "JAN 23, 2018", "JAN 9, 2018", "JAN 3, 2018", "DEC 13, 2017", "OCT 31, 2017", "OCT 31, 2017", "OCT 27, 2017", "SEP 15, 2017", "DEC 4, 2017", "NOV 2, 2017", "AUG 14, 2017", "AUG 10, 2017", "AUG 4, 2017", "AUG 1, 2017", "AUG 1, 2017", "SEP 5, 2017", "AUG 22, 2017", "AUG 19, 2017", "JUL 18, 2017", "JUL 11, 2017", "JUL 7, 2017", "JUL 5, 2017", "JUL 5, 2017", "AUG 1, 2017", "JUN 22, 2017", "JUN 22, 2017", "JUN 21, 2017", "JUN 16, 2017", "JUN 16, 2017", "JUN 16, 2017", "JUN 13, 2017", "JUN 27, 2017", "MAY 26, 2017", "MAY 22, 2017", "MAY 15, 2017", "MAY 10, 2017", "MAY 4, 2017", "MAY 3, 2017", "MAY 3, 2017", "JUN 10, 2017", "APR 28, 2017", "APR 20, 2017", "APR 18, 2017", "APR 15, 2017", "APR 12, 2017", "APR 11, 2017", "APR 10, 2017", "MAY 1, 2017", "APR 28, 2017", "APR 20, 2017", "APR 18, 2017", "APR 15, 2017", "APR 12, 2017", "APR 11, 2017", "APR 10, 2017", "MAY 1, 2017", "APR 10, 2017", "MAR 21, 2017", "MAR 2, 2017", "JAN 19, 2017", "JAN 6, 2017", "JAN 5, 2017", "DEC 26, 2016", "FEB 9, 2017", "FEB 1, 2017", "DEC 9, 2016", "DEC 7, 2016", "NOV 20, 2016", "NOV 4, 2016", "NOV 4, 2016", "DEC 19, 2016", "NOV 3, 2016", "NOV 2, 2016", "NOV 2, 2016", "NOV 2, 2016", "NOV 2, 2016", "NOV 2, 2016", "NOV 1, 2016", "NOV 4, 2016", "NOV 1, 2016", "OCT 28, 2016", "OCT 28, 2016", "OCT 27, 2016", "OCT 27, 2016", "OCT 25, 2016", "OCT 21, 2016", "NOV 1, 2016", "OCT 20, 2016", "OCT 18, 2016", "OCT 18, 2016", "OCT 18, 2016", "OCT 18, 2016", "OCT 17, 2016", "OCT 17, 2016", "OCT 21, 2016", "OCT 17, 2016", "OCT 14, 2016", "OCT 14, 2016", "OCT 13, 2016", "OCT 12, 2016", "OCT 12, 2016", "OCT 12, 2016", "OCT 17, 2016", "OCT 6, 2016", "OCT 6, 2016", "OCT 5, 2016", "OCT 5, 2016", "OCT 5, 2016", "OCT 5, 2016", "OCT 5, 2016", "OCT 7, 2016", "SEP 29, 2016", "SEP 27, 2016", "SEP 26, 2016", "SEP 26, 2016", "SEP 24, 2016", "SEP 23, 2016", "SEP 23, 2016", "OCT 4, 2016", "SEP 21, 2016", "SEP 20, 2016", "SEP 20, 2016", "SEP 20, 2016", "SEP 20, 2016", "SEP 19, 2016", "SEP 19, 2016", "SEP 21, 2016", "SEP 21, 2016", "SEP 15, 2016", "SEP 15, 2016", "SEP 15, 2016", "SEP 15, 2016", "SEP 15, 2016", "SEP 14, 2016", "SEP 16, 2016", "SEP 16, 2016", "SEP 15, 2016", "SEP 15, 2016", "SEP 13, 2016", "SEP 12, 2016", "SEP 12, 2016", "SEP 12, 2016", "SEP 14, 2016", "SEP 13, 2016", "SEP 13, 2016", "SEP 13, 2016", "SEP 12, 2016", "SEP 12, 2016", "SEP 12, 2016", "SEP 12, 2016", "SEP 12, 2016", "SEP 9, 2016", "SEP 9, 2016", "SEP 9, 2016", "SEP 8, 2016", "SEP 8, 2016", "SEP 8, 2016", "SEP 7, 2016", "SEP 11, 2016", "SEP 6, 2016", "SEP 5, 2016", "SEP 2, 2016", "SEP 2, 2016", "SEP 2, 2016", "SEP 1, 2016", "SEP 1, 2016", "SEP 7, 2016", "AUG 30, 2016", "AUG 25, 2016", "AUG 25, 2016", "AUG 24, 2016", "AUG 23, 2016", "AUG 23, 2016", "AUG 31, 2016", "AUG 30, 2016", "AUG 30, 2016", "AUG 25, 2016", "AUG 18, 2016", "AUG 18, 2016", "AUG 17, 2016", "AUG 23, 2016", "AUG 17, 2016", "AUG 17, 2016", "AUG 16, 2016", "AUG 16, 2016", "AUG 16, 2016", "AUG 16, 2016", "AUG 11, 2016", "AUG 17, 2016", "AUG 10, 2016", "AUG 10, 2016", "AUG 10, 2016", "AUG 10, 2016", "AUG 10, 2016", "AUG 9, 2016", "AUG 9, 2016", "AUG 10, 2016", "AUG 10, 2016", "AUG 10, 2016", "AUG 8, 2016", "AUG 5, 2016", "AUG 5, 2016", "AUG 5, 2016", "AUG 5, 2016", "AUG 9, 2016", "AUG 5, 2016", "AUG 5, 2016", "AUG 5, 2016", "AUG 5, 2016", "AUG 4, 2016", "AUG 4, 2016", "AUG 2, 2016", "AUG 5, 2016", "AUG 5, 2016", "AUG 5, 2016", "AUG 5, 2016", "AUG 5, 2016", "JUN 25, 2016", "JUN 17, 2016", "JUN 3, 2016", "AUG 1, 2016", "MAY 6, 2016", "MAY 4, 2016", "MAY 3, 2016", "APR 24, 2016", "APR 7, 2016", "APR 4, 2016", "MAR 31, 2016", "MAY 29, 2016", "MAR 28, 2016", "MAR 22, 2016", "MAR 18, 2016", "MAR 15, 2016", "MAR 8, 2016", "FEB 26, 2016", "FEB 23, 2016", "MAR 29, 2016", "FEB 11, 2016", "FEB 11, 2016", "FEB 7, 2016", "FEB 6, 2016", "JAN 21, 2016", "JAN 15, 2016", "JAN 12, 2016", "FEB 20, 2016", "FEB 11, 2016", "FEB 11, 2016", "DEC 27, 2015", "DEC 19, 2015", "DEC 10, 2015", "DEC 4, 2015", "JAN 11, 2016", "NOV 30, 2015", "NOV 11, 2015", "NOV 6, 2015", "NOV 2, 2015", "OCT 27, 2015", "OCT 15, 2015", "OCT 7, 2015", "DEC 3, 2015", "SEP 16, 2015", "SEP 11, 2015", "SEP 10, 2015", "SEP 9, 2015", "SEP 3, 2015", "SEP 3, 2015", "SEP 3, 2015", "SEP 25, 2015", "SEP 16, 2015", "SEP 11, 2015", "SEP 10, 2015", "JUL 2, 2015", "JUN 30, 2015", "JUN 24, 2015", "SEP 3, 2015", "MAY 1, 2015", "MAY 1, 2015", "APR 22, 2015", "APR 21, 2015", "APR 21, 2015", "APR 15, 2015", "APR 9, 2015", "MAY 26, 2015", "MAY 1, 2015", "MAY 1, 2015", "MAR 2, 2015", "FEB 9, 2015", "JAN 7, 2015", "DEC 29, 2014", "APR 7, 2015", "DEC 10, 2014", "DEC 5, 2014", "DEC 5, 2014", "DEC 2, 2014", "NOV 29, 2014", "NOV 21, 2014", "NOV 19, 2014", "DEC 17, 2014", "NOV 14, 2014", "NOV 14, 2014", "NOV 5, 2014", "NOV 3, 2014", "NOV 3, 2014", "NOV 3, 2014", "NOV 3, 2014", "NOV 19, 2014", "SEP 28, 2014", "SEP 23, 2014", "SEP 8, 2014", "JUL 1, 2014", "JUN 25, 2014", "JUN 16, 2014", "JUN 13, 2014", "OCT 13, 2014", "JUN 12, 2014", "JUN 12, 2014", "JUN 12, 2014", "JUN 12, 2014", "JUN 12, 2014", "JUN 11, 2014", "MAY 13, 2014", "JUN 12, 2014", "JUN 12, 2014", "JUN 12, 2014", "JUN 12, 2014", "MAR 25, 2014", "MAR 25, 2014", "MAR 19, 2014", "MAY 13, 2014", "MAY 5, 2014", "MAR 12, 2014", "MAR 12, 2014", "MAR 12, 2014", "MAR 12, 2014", "FEB 26, 2014", "MAR 18, 2014", "MAR 18, 2014", "MAR 13, 2014", "JAN 27, 2014", "JAN 27, 2014", "JAN 27, 2014", "JAN 13, 2014", "JAN 31, 2014", "DEC 10, 2013", "DEC 10, 2013", "DEC 10, 2013", "DEC 6, 2013", "DEC 6, 2013", "DEC 6, 2013", "NOV 12, 2013", "DEC 31, 2013", "OCT 16, 2013", "OCT 16, 2013", "AUG 12, 2013", "MAY 7, 2013", "APR 29, 2013", "APR 7, 2013", "MAR 14, 2013", "NOV 11, 2013", "OCT 16, 2013", "OCT 16, 2013", "NOV 16, 2012", "OCT 31, 2012", "SEP 11, 2012", "SEP 10, 2012", "AUG 1, 2012", "MAR 12, 2013", "APR 2, 2012", "MAR 9, 2012", "NOV 16, 2011", "JUL 8, 2011", "JUN 7, 2011", "MAR 1, 2011", "MAR 1, 2011", "MAY 3, 2012", "OCT 13, 2010", "JAN 12, 2010", "NOV 22, 2010"], "Published Date": [], "Link": ["https://www.nasdaq.com/articles/geron-corporation-delaware-gern-q1-2020-earnings-call-transcript-2020-05-29", "https://www.nasdaq.com/articles/earnings-summary%3A-details-of-geron-corporation-q1-earnings-report-2020-05-28", "https://www.nasdaq.com/articles/geron-q1-20-earnings-conference-call-at-4%3A30-pm-et-2020-05-28", "https://www.nasdaq.com/articles/buzz-u.s.-stocks-on-the-move-tetraphase-pharma-aurora-cannabis-hpe-2020-05-22", "https://www.nasdaq.com/articles/why-geron-stock-soared-23.4-today-2020-05-15", "https://www.nasdaq.com/articles/3-strong-buy-penny-stocks-with-triple-digit-upside-2020-05-14", "https://www.nasdaq.com/articles/7-penny-stocks-to-buy-with-massive-upside-potential-2020-04-08", "https://www.nasdaq.com/articles/geron-%3A-clinical-trial-activities-impacted-by-covid-19-pandemic-cuts-spending-2020-04-02", "https://www.nasdaq.com/articles/geron-corporation-delaware-gern-q1-2020-earnings-call-transcript-2020-05-29", "https://www.nasdaq.com/articles/geron-corporation-delaware-gern-q4-2019-earnings-call-transcript-2020-03-13", "https://www.nasdaq.com/articles/earnings-summary%3A-details-of-geron-corporation-q4-earnings-report-2020-03-12", "https://www.nasdaq.com/articles/geron-q4-19-earnings-conference-call-at-4%3A30-pm-et-2020-03-12", "https://www.nasdaq.com/articles/is-geron-stock-a-buy-2020-01-29", "https://www.nasdaq.com/articles/7-healthcare-stocks-with-100-street-support-2020-01-22", "https://www.nasdaq.com/articles/does-geron-corporation-stock-belong-in-your-portfolio-in-2020-2020-01-22", "https://www.nasdaq.com/articles/better-buy%3A-geron-vs.-incyte-2020-01-07", "https://www.nasdaq.com/articles/better-buy%3A-geron-vs.-acceleron-2020-03-27", "https://www.nasdaq.com/articles/earnings-summary%3A-details-of-geron-corporation-q3-earnings-report-2019-11-06", "https://www.nasdaq.com/articles/better-buy%3A-geron-vs.-celgene-2019-10-19", "https://www.nasdaq.com/articles/health-care-sector-update-for-10-11-2019%3A-clvsgernacrshexohexo.to-2019-10-11", "https://www.nasdaq.com/articles/health-care-sector-update-for-10-11-2019%3A-gernacrshexo-2019-10-11", "https://www.nasdaq.com/articles/health-care-sector-update-for-10-11-2019%3A-acrs-gern-gild-glpg-jnj-pfe-abt-mrk-amgn-2019-10", "https://www.nasdaq.com/articles/3-top-small-cap-stocks-to-buy-in-october-2019-10-03", "https://www.nasdaq.com/articles/health-care-sector-update-for-10-01-2019%3A-eyesbcdagernnlnk-2019-10-01", "https://www.nasdaq.com/articles/geron-corporation-delaware-gern-q3-2019-earnings-call-transcript-2019-11-08", "https://www.nasdaq.com/articles/health-care-sector-update-for-10-01-2019%3A-gern-gnft-anab-jnj-pfe-abt-mrk-amgn-2019-10-01", "https://www.nasdaq.com/articles/2-biotech-stocks-i-wouldnt-touch-with-a-broom-2019-09-21", "https://www.nasdaq.com/articles/geron-corporation-delaware-gern-q2-2019-earnings-call-transcript-2019-08-06", "https://www.nasdaq.com/articles/what-youll-want-to-know-about-gerons-q2-results-2019-08-02", "https://www.nasdaq.com/articles/why-geron-corporation-stock-bolted-higher-in-the-first-half-of-2019-2019-07-08", "https://www.nasdaq.com/articles/did-gerons-big-announcement-just-go-unnoticed-2019-05-16", "https://www.nasdaq.com/articles/3-cancer-treatment-stocks-buy-april-2019-04-20", "https://www.nasdaq.com/articles/why-geron-stock-is-jumping-today-2019-10-01", "https://www.nasdaq.com/articles/health-care-sector-update-for-10-01-2019%3A-gern-gnft-anab-jnj-pfe-abt-mrk-amgn-2019-10-01", "https://www.nasdaq.com/articles/2-biotech-stocks-i-wouldnt-touch-with-a-broom-2019-09-21", "https://www.nasdaq.com/articles/gerons-gern-q4-loss-in-line-revenues-beat-stock-up-2019-03-08", "https://www.nasdaq.com/articles/geron-corportaion-gern-q4-2018earnings-conference-call-transcript-2019-03-07", "https://www.nasdaq.com/articles/earnings-reaction-history-geron-corp-714-follow-through-indicator-135-sensitive-2019-03-07", "https://www.nasdaq.com/articles/why-geron-skyrocketed-27-february-2019-03-05", "https://www.nasdaq.com/articles/3-oldest-members-biotechs-billion-burned-club-2019-03-03", "https://www.nasdaq.com/articles/3-penny-stocks-could-make-you-rich-or-regretful-2019-03-14", "https://www.nasdaq.com/articles/why-geron-stock-briefly-spiked-today-2019-02-13", "https://www.nasdaq.com/articles/are-options-traders-betting-on-a-big-move-in-geron-gern-stock-2019-02-06", "https://www.nasdaq.com/articles/why-geron-stock-dropped-44-2018-2019-01-15", "https://www.nasdaq.com/articles/geron-names-ceo-john-scarlett-chairman-succeeding-hoyoung-huh-2018-12-31", "https://www.nasdaq.com/articles/here-are-biotechs-big-pipeline-disappointments-2018-2018-12-18", "https://www.nasdaq.com/articles/top-10-healthcare-stories-2018-2018-12-13", "https://www.nasdaq.com/articles/health-care-sector-update-12042018-gernclvspsti-2018-12-04", "https://www.nasdaq.com/articles/could-geron-be-millionaire-maker-stock-2019-02-23", "https://www.nasdaq.com/articles/how-gerons-horrible-year-great-reminder-investors-2018-11-02", "https://www.nasdaq.com/articles/gerons-gern-q3-earnings-beat-revenues-miss-shares-down-2018-11-02", "https://www.nasdaq.com/articles/geron-gern-reports-q3-loss-misses-revenue-estimates-2018-11-02", "https://www.nasdaq.com/articles/scary-markets-frightening-stocks-and-how-keep-panicking-2018-11-01", "https://www.nasdaq.com/articles/why-geron-corporation-stock-ripping-higher-today-2018-11-01", "https://www.nasdaq.com/articles/geron-gern-stock-moves-0.58%3A-what-you-should-know-2018-10-10", "https://www.nasdaq.com/articles/heres-why-geron-plummeted-69-september-2018-10-09", "https://www.nasdaq.com/articles/geron-gern-down-13-since-last-earnings-report%3A-can-it-rebound-2018-12-01", "https://www.nasdaq.com/articles/are-these-beaten-down-clinical-stage-biotech-stocks-buys-2018-10-08", "https://www.nasdaq.com/articles/geron-stock-buy-sell-or-hold-2018-10-08", "https://www.nasdaq.com/articles/biotech-stock-roundup%3A-alxn-on-acquisition-spree-fda-nod-for-regn-amgn-drugs-2018-10-03", "https://www.nasdaq.com/articles/2-stocks-could-benefit-big-gerons-stumble-2018-09-29", "https://www.nasdaq.com/articles/mid-day-market-update-crude-oil-15-altimmune-shares-plunge-2018-09-28", "https://www.nasdaq.com/articles/why-geron-corporations-stock-sinking-again-2018-09-28", "https://www.nasdaq.com/articles/mid-morning-market-update-markets-edge-lower-blackberry-earnings-beat-expectations-2018-09", "https://www.nasdaq.com/articles/do-options-traders-know-something-about-geron-gern-stock-we-dont-2018-10-09", "https://www.nasdaq.com/articles/can-geron-corporation-recover-its-breakup-johnson-johnson-2018-09-28", "https://www.nasdaq.com/articles/after-its-disastrous-day-whats-next-geron-corp-2018-09-28", "https://www.nasdaq.com/articles/pre-market-most-active-sep-28-2018-tsla-gern-fcau-tlry-qqq-vale-tvix-dtea-db-bac-nok-lyg", "https://www.nasdaq.com/articles/better-buy-geron-corporation-vs-incyte-corporation-2018-09-28", "https://www.nasdaq.com/articles/mid-afternoon-market-update-progress-software-falls-following-mixed-q3-results", "https://www.nasdaq.com/articles/mid-day-market-update-dow-rises-over-100-points-geron-shares-plunge-2018-09-27", "https://www.nasdaq.com/articles/mid-morning-market-update-markets-open-higher-conagra-misses-q1-views-2018-09-27", "https://www.nasdaq.com/articles/gerons-stock-plunges-as-jj-ends-imetelstat-collaboration-2018-09-28", "https://www.nasdaq.com/articles/pre-market-most-active-sep-27-2018-gern-bbby-unm-grpn-lone-skx-aapl-mu-bj-fcx-arnc-ccj", "https://www.nasdaq.com/articles/us-futures-point-north-after-fed-rate-hike-data-focus-2018-09-27", "https://www.nasdaq.com/articles/why-geron-corporations-stock-getting-hammered-today-2018-09-27", "https://www.nasdaq.com/articles/why-bed-bath-beyond-geron-and-canopy-growth-slumped-today-2018-09-27", "https://www.nasdaq.com/articles/5-top-stock-trades-friday-bbby-rad-and-nflx-2018-09-27", "https://www.nasdaq.com/articles/mid-afternoon-market-update-bed-bath-beyond-drops-following-weak-q2-results-cameco-shares", "https://www.nasdaq.com/articles/health-care-sector-update-09272018-wcg-aet-cvs-gwph-gern-jnj-2018-09-27", "https://www.nasdaq.com/articles/wall-street-set-gains-after-fed-rate-hike-q2-gdp-growth-steady-42-2018-09-27", "https://www.nasdaq.com/articles/7-biotech-stocks-buy-now-2018-09-19", "https://www.nasdaq.com/articles/options-traders-expect-huge-moves-in-geron-gern-stock-2018-09-13", "https://www.nasdaq.com/articles/geron-corp-lost-translation-2018-09-12", "https://www.nasdaq.com/articles/geron-corporation-sober-assessment-2018-09-11", "https://www.nasdaq.com/articles/noteworthy-tuesday-option-activity-txn-gern-v-2018-09-11", "https://www.nasdaq.com/articles/3-biotech-stocks-still-have-major-catalysts-september-2018-09-05", "https://www.nasdaq.com/articles/3-top-stocks-under-10-2018-09-05", "https://www.nasdaq.com/articles/why-geron-corporation-stock-bolting-higher-today-2018-09-24", "https://www.nasdaq.com/articles/7-biotech-stocks-buy-now-2018-09-19", "https://www.nasdaq.com/articles/options-traders-expect-huge-moves-in-geron-gern-stock-2018-09-13", "https://www.nasdaq.com/articles/why-is-geron-gern-up-58-since-last-earnings-report-2018-08-30", "https://www.nasdaq.com/articles/why-geron-corporations-stock-charging-higher-today-2018-08-28", "https://www.nasdaq.com/articles/johnson-johnson-hiring-and-its-ginormous-news-geron-2018-08-28", "https://www.nasdaq.com/articles/why-yum-china-holdings-brooks-automation-and-geron-jumped-today-2018-08-28", "https://www.nasdaq.com/articles/has-geron-corporations-stock-been-de-risked-2018-08-27", "https://www.nasdaq.com/articles/geron-stock-up-more-than-200-in-2018-so-far%3A-heres-why-2018-09-04", "https://www.nasdaq.com/articles/noteworthy-monday-option-activity-gern-fit-ftv-2018-08-27", "https://www.nasdaq.com/articles/mid-day-update-wall-street-higher-powell-sticks-rate-hike-course-2018-08-24", "https://www.nasdaq.com/articles/geron-corporation-stock-shoots-up-on-job-posting-news-2018-08-24", "https://www.nasdaq.com/articles/noteworthy-friday-option-activity-xlrn-gern-cal-2018-08-17", "https://www.nasdaq.com/articles/better-speculative-biotech-stock-amarin-corporation-vs-geron-corporation-2018-08-16", "https://www.nasdaq.com/articles/implied-volatility-surging-for-geron-gern-stock-options-2018-08-13", "https://www.nasdaq.com/articles/3-reasons-geron-corporation-stock-could-be-big-winner-2018-08-06", "https://www.nasdaq.com/articles/pre-market-most-active-aug-27-2018-cron-tsla-tlry-cgc-aks-gern-tkc-baba-qqq-nflx-qd-teva", "https://www.nasdaq.com/articles/noteworthy-monday-option-activity-gern-fit-ftv-2018-08-27", "https://www.nasdaq.com/articles/mid-day-update-wall-street-higher-powell-sticks-rate-hike-course-2018-08-24", "https://www.nasdaq.com/articles/geron-corporation-stock-shoots-up-on-job-posting-news-2018-08-24", "https://www.nasdaq.com/articles/why-geron-corp-stock-has-skyrocketed-906-2018-so-far-2018-07-06", "https://www.nasdaq.com/articles/why-geron-corporation-stock-heading-higher-today-2018-06-18", "https://www.nasdaq.com/articles/after-hours-most-active-jun-15-2018-endp-rrc-hfc-br-gern-qqq-aapl-bac-csco-opk-ge-wfc-2018", "https://www.nasdaq.com/articles/notable-friday-option-activity-xom-gern-pfe-2018-06-15", "https://www.nasdaq.com/articles/geron-gern-q2-loss-in-line-revenues-up-y-y-shares-down-2018-08-01", "https://www.nasdaq.com/articles/3-likely-reasons-geron-stock-sizzling-hot-right-now-2018-05-25", "https://www.nasdaq.com/articles/what-geron-corporations-downside-risk-2018-05-25", "https://www.nasdaq.com/articles/why-geron-corporation-stock-heating-2018-05-23", "https://www.nasdaq.com/articles/huge-decision-tap-little-biotech-stock-2018-05-16", "https://www.nasdaq.com/articles/implied-volatility-surging-for-geron-gern-stock-options-2018-05-16", "https://www.nasdaq.com/articles/is-geron-gern-outperforming-other-medical-stocks-this-year-2018-05-14", "https://www.nasdaq.com/articles/geron-gern-q1-loss-narrows-y-y-revenues-fall-shares-down-2018-05-11", "https://www.nasdaq.com/articles/these-3-stocks-shot-50-2017-are-they-still-buys-2018-05-29", "https://www.nasdaq.com/articles/health-care-sector-update-05112018-sbotsupnakcagern-2018-05-11", "https://www.nasdaq.com/articles/health-care-sector-update-05112018-gernsbot-2018-05-11", "https://www.nasdaq.com/articles/why-geron-corporation-stock-sank-last-month-2018-05-04", "https://www.nasdaq.com/articles/whats-in-the-cards-for-geron-gern-this-earnings-season-2018-05-03", "https://www.nasdaq.com/articles/is-geron-corporation-gern-stock-outpacing-its-medical-peers-this-year-2018-04-25", "https://www.nasdaq.com/articles/geron-corporation-clock-ticking-2018-04-23", "https://www.nasdaq.com/articles/pre-market-most-active-apr-17-2018-nflx-tvix-sqqq-qqq-gs-rio-twtr-bac-baba-chk-gern-roku", "https://www.nasdaq.com/articles/health-care-sector-update-05112018-sbot-azn-gern-2018-05-11", "https://www.nasdaq.com/articles/heres-why-geron-stock-surged-more-than-90-in-6-months-2018-04-13", "https://www.nasdaq.com/articles/pre-market-most-active-apr-13-2018-bac-tvix-hdb-jpm-mfgp-c-chl-mu-gern-dbx-qqq-nflx-2018", "https://www.nasdaq.com/articles/why-geron-corporation-stock-popped-84-march-2018-04-13", "https://www.nasdaq.com/articles/why-geron-corporation-stock-rise-today-2018-04-12", "https://www.nasdaq.com/articles/thursday-sector-leaders-biotechnology-railroads-2018-04-12", "https://www.nasdaq.com/articles/3-reasons-clinical-stage-biotech-incredible-bargain-2018-04-09", "https://www.nasdaq.com/articles/why-geron-corporations-stock-heading-higher-today-2018-04-17", "https://www.nasdaq.com/articles/are-short-sellers-right-about-geron-corporation-2018-04-02", "https://www.nasdaq.com/articles/these-3-biotech-stocks-are-soaring-are-they-buys-now-2018-03-29", "https://www.nasdaq.com/articles/incyte-could-have-problem-or-2-its-hands-2018-03-29", "https://www.nasdaq.com/articles/geron-corp-skyrocketed-and-abbvie-inc-crashed-are-these-stocks-buys-2018-03-29", "https://www.nasdaq.com/articles/heres-why-gerons-stock-cratering-today-2018-03-28", "https://www.nasdaq.com/articles/why-geron-corporation-stock-crashing-today-2018-03-27", "https://www.nasdaq.com/articles/pre-market-most-active-mar-27-2018-qqq-fb-ge-mu-tvix-gern-uslv-gsk-bac-baba-db-rio-2018-03", "https://www.nasdaq.com/articles/why-geron-corporation-stock-falling-today-2018-04-02", "https://www.nasdaq.com/articles/3-biotech-stocks-skyrocketed-week-are-they-buys-2018-03-24", "https://www.nasdaq.com/articles/why-geron-corp-rallying-10-today-2018-03-23", "https://www.nasdaq.com/articles/geron-corporation-stock-still-strong-buy-2018-03-22", "https://www.nasdaq.com/articles/why-geron-corporation-stock-big-again-today-2018-03-21", "https://www.nasdaq.com/articles/heres-why-geron-corporation-stock-popped-today-2018-03-19", "https://www.nasdaq.com/articles/mid-day-market-update-dow-falls-over-300-points-klondex-mines-shares-spike-higher-2018-03", "https://www.nasdaq.com/articles/geron-gern-q4-loss-flat-y-y-revenues-surge-shares-up-2018-03-19", "https://www.nasdaq.com/articles/why-twitter-overstockcom-and-geron-slumped-today-2018-03-27", "https://www.nasdaq.com/articles/health-care-sector-update-03192018-mdwd-regn-cdtx-gern-2018-03-19", "https://www.nasdaq.com/articles/pre-market-most-active-mar-19-2018-fb-qqq-mu-tvix-mfgp-csra-gern-sqqq-sbgl-nok-baba-db", "https://www.nasdaq.com/articles/geron-gern-q4-2017-earnings-conference-call-transcript-2018-03-19", "https://www.nasdaq.com/articles/why-canadian-solar-geron-and-novagold-resources-jumped-today-2018-03-19", "https://www.nasdaq.com/articles/health-care-sector-update-03192018-cdtxmdwdgernregn-2018-03-19", "https://www.nasdaq.com/articles/mid-afternoon-market-update-nasdaq-slides-over-25-micro-focus-shares-plummet-2018-03-19", "https://www.nasdaq.com/articles/health-care-sector-update-03192018-mdwdgernregn-2018-03-19", "https://www.nasdaq.com/articles/mid-morning-market-update-markets-open-lower-kla-tencor-buy-orbotech-2018-03-19", "https://www.nasdaq.com/articles/geron-gern-in-focus%3A-stock-moves-10.8-higher-2018-03-16", "https://www.nasdaq.com/articles/jjs-jnj-erdafitinib-gets-breakthrough-therapy-status-2018-03-16", "https://www.nasdaq.com/articles/after-hours-earnings-report-march-16-2018-gern-aten-2018-03-16", "https://www.nasdaq.com/articles/mid-day-market-update-dow-rises-over-200-points-invuity-shares-plummet-2018-03-15", "https://www.nasdaq.com/articles/heres-why-shorting-geron-corporation-stock-terrible-idea-2018-03-15", "https://www.nasdaq.com/articles/mid-afternoon-market-update-image-sensing-systems-gains-following-q4-results-jjill-shares", "https://www.nasdaq.com/articles/why-geron-corporation-stock-rising-today-2018-03-13", "https://www.nasdaq.com/articles/geron-corporations-stock-set-sail-or-sink-2018-03-18", "https://www.nasdaq.com/articles/whats-in-the-cards-for-geron-gern-this-earnings-season-2018-02-20", "https://www.nasdaq.com/articles/5-risky-rewarding-ways-play-rebound-2018-02-07", "https://www.nasdaq.com/articles/why-geron-corporation-stock-ripped-higher-january-2018-02-04", "https://www.nasdaq.com/articles/3-biotech-stocks-soared-week-are-they-buys-2018-02-03", "https://www.nasdaq.com/articles/mid-afternoon-market-update-crude-oil-down-15-natural-grocers-shares-drop-earnings-miss", "https://www.nasdaq.com/articles/geron-stock-heating-time-buy-2018-01-31", "https://www.nasdaq.com/articles/mondays-etf-movers-xbi-gdxj-2018-01-29", "https://www.nasdaq.com/articles/3-top-biotech-stocks-buy-march-2018-03-06", "https://www.nasdaq.com/articles/geron-corporations-13-drop-2017-explained-2018-01-09", "https://www.nasdaq.com/articles/3-stocks-feel-microsoft-1986-2018-01-03", "https://www.nasdaq.com/articles/5-biotech-buyout-candidates-2018-2017-12-13", "https://www.nasdaq.com/articles/3-top-healthcare-stocks-buy-december-2017-12-12", "https://www.nasdaq.com/articles/paratek-pharmaceuticals-set-explode-holy-grail-antibiotics-omadacycline-nears-fda-approval", "https://www.nasdaq.com/articles/3-stocks-hold-next-20-years-2017-12-11", "https://www.nasdaq.com/articles/2-reasons-geron-corporation-took-pounding-november-2017-12-06", "https://www.nasdaq.com/articles/3-stocks-feel-disney-1957-2018-01-23", "https://www.nasdaq.com/articles/geron-corporations-13-drop-2017-explained-2018-01-09", "https://www.nasdaq.com/articles/3-stocks-feel-microsoft-1986-2018-01-03", "https://www.nasdaq.com/articles/5-biotech-buyout-candidates-2018-2017-12-13", "https://www.nasdaq.com/articles/pre-market-most-active-oct-31-2017-ua-uaa-intc-mu-teva-aapl-shop-qcom-gern-ll-baba-mdlz", "https://www.nasdaq.com/articles/3-stocks-microsoft-return-potential-2017-10-31", "https://www.nasdaq.com/articles/whats-in-the-cards-for-geron-gern-this-earnings-season-2017-10-27", "https://www.nasdaq.com/articles/smartest-move-johnson-johnson-has-made-all-year-2017-09-15", "https://www.nasdaq.com/articles/1-high-risk-penny-stock-may-be-worth-buying-2017-12-04", "https://www.nasdaq.com/articles/geron-gern-q3-loss-narrower-than-expected-sales-miss-2017-11-02", "https://www.nasdaq.com/articles/gerons-gern-imetelstat-progressing-well-setbacks-concern-2017-08-14", "https://www.nasdaq.com/articles/geron-gern-q2-loss-narrows-sales-miss-estimates-stock-up-2017-08-10", "https://www.nasdaq.com/articles/johnson-johnsons-3-biggest-sources-growth-over-next-10-years-2017-08-04", "https://www.nasdaq.com/articles/mid-day-market-update-pitney-bowes-drops-earnings-miss-lumber-liquidators-shares-climb", "https://www.nasdaq.com/articles/why-pitney-bowes-geron-and-cummins-slumped-today-2017-08-01", "https://www.nasdaq.com/articles/key-reason-incyte-corporation-added-850-million-market-cap-august-2017-09-05", "https://www.nasdaq.com/articles/3-top-stocks-under-5-2017-08-22", "https://www.nasdaq.com/articles/3-stocks-under-5-could-make-you-rich-2017-07-23", "https://www.nasdaq.com/articles/3-healthcare-stocks-ambitious-investors-2017-07-18", "https://www.nasdaq.com/articles/3-stocks-billionaires-cant-buy-you-can-2017-07-11", "https://www.nasdaq.com/articles/heres-why-johnson-johnson-valued-its-highest-pe-decade-2017-07-07", "https://www.nasdaq.com/articles/why-geron-gern-might-be-a-diamond-in-the-rough-2017-07-05", "https://www.nasdaq.com/articles/geron-stock-up-almost-40-so-far-this-year-after-16-decline-2017-07-05", "https://www.nasdaq.com/articles/heres-why-geron-corporation-fell-much-166-today-2017-08-01", "https://www.nasdaq.com/articles/heres-why-geron-gern-is-a-good-stock-to-invest-in-now-2017-06-22", "https://www.nasdaq.com/articles/the-zacks-analyst-blog-highlights%3A-cambrex-geron-anavex-life-sciences-and-histogenics-2017", "https://www.nasdaq.com/articles/fresh-capital-be-injected-biotech-stocks-5-must-buys-2017-06-21", "https://www.nasdaq.com/articles/3-hiddem-gems-healthcare-sector-2017-06-16", "https://www.nasdaq.com/articles/omeros-omer-hits-new-52-week-high-on-positive-fda-decision-2017-06-16", "https://www.nasdaq.com/articles/mallinckrodt-initiates-amyotrophic-lateral-sclerosis-study-2017-06-16", "https://www.nasdaq.com/articles/geron-gern-up-3.1-since-earnings-report%3A-can-it-continue-2017-06-13", "https://www.nasdaq.com/articles/5-biomedical-stocks-are-expected-surge-2017-06-27", "https://www.nasdaq.com/articles/johnson-johnsons-analyst-day-was-overshadowed-worrisome-data-2017-05-26", "https://www.nasdaq.com/articles/these-3-biotech-stocks-have-ballooned-2017-will-they-pop-2017-05-22", "https://www.nasdaq.com/articles/geron-corp-gern-worth-a-look%3A-stock-adds-7-in-session-2017-05-15", "https://www.nasdaq.com/articles/geron-gern-q1-loss-in-line-focus-remains-on-imetelstat-2017-05-10", "https://www.nasdaq.com/articles/3-biotech-stocks-projected-grow-their-eps-least-415-2018-2017-05-04", "https://www.nasdaq.com/articles/johnson-johnsons-5-dividend-increase-offers-big-clue-about-its-future-2017-05-03", "https://www.nasdaq.com/articles/major-catalyst-sent-geron-corporation-shares-higher-13-april-2017-05-03", "https://www.nasdaq.com/articles/3-stocks-zillow-return-potential-2017-06-10", "https://www.nasdaq.com/articles/will-geron-gern-continue-to-surge-higher-2017-04-28", "https://www.nasdaq.com/articles/26-billion-company-markets-most-overpriced-biotech-stock-2017-04-20", "https://www.nasdaq.com/articles/top-ranked-momentum-stocks-to-buy-for-april-18th-2017-04-18", "https://www.nasdaq.com/articles/3-stocks-ripe-buyout-2017-04-15", "https://www.nasdaq.com/articles/biotech-stock-roundup-geron-gains-interim-data-oncomed-slumps-pipeline-setback-2017-04-12", "https://www.nasdaq.com/articles/geron-stock-rises-after-positive-interim-update-on-imetelstat-2017-04-11", "https://www.nasdaq.com/articles/why-geron-corporation-stock-surging-higher-today-2017-04-10", "https://www.nasdaq.com/articles/geron-gern-q1-earnings%3A-whats-in-store-for-the-stock-2017-05-01", "https://www.nasdaq.com/articles/will-geron-gern-continue-to-surge-higher-2017-04-28", "https://www.nasdaq.com/articles/26-billion-company-markets-most-overpriced-biotech-stock-2017-04-20", "https://www.nasdaq.com/articles/top-ranked-momentum-stocks-to-buy-for-april-18th-2017-04-18", "https://www.nasdaq.com/articles/3-stocks-ripe-buyout-2017-04-15", "https://www.nasdaq.com/articles/biotech-stock-roundup-geron-gains-interim-data-oncomed-slumps-pipeline-setback-2017-04-12", "https://www.nasdaq.com/articles/geron-stock-rises-after-positive-interim-update-on-imetelstat-2017-04-11", "https://www.nasdaq.com/articles/why-geron-corporation-stock-surging-higher-today-2017-04-10", "https://www.nasdaq.com/articles/geron-gern-q1-earnings%3A-whats-in-store-for-the-stock-2017-05-01", "https://www.nasdaq.com/articles/why-knight-transportation-geron-and-rent-center-jumped-today-2017-04-10", "https://www.nasdaq.com/articles/4-biotech-stocks-jaw-dropping-growth-potential-2017-03-21", "https://www.nasdaq.com/articles/geron-gern-q4-loss-narrows-focus-remains-on-imetelstat-2017-03-02", "https://www.nasdaq.com/articles/3-beaten-down-biotech-stocks-you-can-buy-right-now-2017-01-19", "https://www.nasdaq.com/articles/fridays-etf-movers-xbi-gdxj-2017-01-06", "https://www.nasdaq.com/articles/3-reasons-geron-corporation-plunged-57-2016-2017-01-05", "https://www.nasdaq.com/articles/4-biotech-stocks-buy-january-2016-12-26", "https://www.nasdaq.com/articles/4-stocks-under-4-could-double-2017-02-09", "https://www.nasdaq.com/articles/forget-anavex-life-sciences-corp-these-2-biotech-stocks-are-better-buys-2017-02-01", "https://www.nasdaq.com/articles/3-beaten-biotech-stocks-are-they-bargains-2016-12-09", "https://www.nasdaq.com/articles/4-small-cap-stocks-worth-buying-2017-2016-12-07", "https://www.nasdaq.com/articles/penny-stocks-2-buy-2-avoid-2016-11-20", "https://www.nasdaq.com/articles/intercept-icpt-q3-loss-narrower-than-expected-sales-miss-2016-11-04", "https://www.nasdaq.com/articles/aegerion-aegr-reports-narrower-than-expected-loss-in-q3-2016-11-04", "https://www.nasdaq.com/articles/3-stocks-under-10-buy-2017-2016-12-19", "https://www.nasdaq.com/articles/alkermes-alks-q3-loss-in-line-sales-miss-16-view-intact-2016-11-03", "https://www.nasdaq.com/articles/amerisourcebergen-abc-q4-earnings-top-revenues-lag-2016-11-02", "https://www.nasdaq.com/articles/gilead-gild-misses-q3-earnings-estimates-retains-view-2016-11-02", "https://www.nasdaq.com/articles/waiting-game-sends-geron-corporation-lower-another-18-october-2016-11-02", "https://www.nasdaq.com/articles/zoetis-zts-tops-q3-earnings-estimates-updates-outlook-2016-11-02", "https://www.nasdaq.com/articles/shire-shpg-misses-q3-earnings-revenue-estimates-2016-11-02", "https://www.nasdaq.com/articles/here-are-johnson-johnsons-next-10-potential-blockbuster-drugs-2016-11-01", "https://www.nasdaq.com/articles/geron-gern-reports-narrower-than-expected-loss-in-q3-2016-11-04", "https://www.nasdaq.com/articles/geron-gern-q3-earnings%3A-will-the-store-pull-a-surprise-2016-11-01", "https://www.nasdaq.com/articles/sarepta-therapeutics-srpt-incurs-narrower-y-y-loss-in-q3-2016-10-28", "https://www.nasdaq.com/articles/acorda-acor-reports-wider-q3-loss-revenues-down-y-y-2016-10-28", "https://www.nasdaq.com/articles/glaxo-gsk-beats-q3-earnings-estimates-keeps-2016-view-2016-10-27", "https://www.nasdaq.com/articles/alexion-alxn-q3-earnings-lag-revenues-tops-lifts-view-2016-10-27", "https://www.nasdaq.com/articles/novartis-nvs-tops-q3-earnings-misses-sales-estimates-2016-10-25", "https://www.nasdaq.com/articles/amgens-amgn-xgeva-meets-endpoint-in-phase-iii-study-2016-10-21", "https://www.nasdaq.com/articles/3-biotech-stocks-could-double-12-months-2016-11-01", "https://www.nasdaq.com/articles/mercks-antiviral-medicine-meets-endpoint-in-phase-iii-2016-10-20", "https://www.nasdaq.com/articles/top-rated-stock-picks-and-popular-stories-nasdaqcom-october-9-15-2016-10-18", "https://www.nasdaq.com/articles/regeneron-teva-hit-by-clinical-hold-on-chronic-pain-study-2016-10-18", "https://www.nasdaq.com/articles/ptc-therapeutics-falls-on-fda-denial-of-dmd-drug-appeal-2016-10-18", "https://www.nasdaq.com/articles/shire-shpg-updates-vyvanse-label-with-new-efficacy-data-2016-10-18", "https://www.nasdaq.com/articles/intercept-icpt-ocaliva-wins-positive-chmp-opinion-for-pbc-2016-10-17", "https://www.nasdaq.com/articles/roches-lucentis-prefilled-syringe-approved-in-the-u.s.-2016-10-17", "https://www.nasdaq.com/articles/roche-rhhby-misses-q3-sales-estimates-2016-view-intact-2016-10-21", "https://www.nasdaq.com/articles/bristol-myers-wins-chmp-nod-for-opdivo-label-expansion-2016-10-17", "https://www.nasdaq.com/articles/oculars-ocul-stock-jumps-on-collaboration-with-regeneron-2016-10-14", "https://www.nasdaq.com/articles/merck-kgaa-offers-portfolio-updates-at-market-day-event-2016-10-14", "https://www.nasdaq.com/articles/celgene-agios-ink-deals-with-abbott-to-identify-idh-mutations-2016-10-13", "https://www.nasdaq.com/articles/merrimacks-onivyde-positive-in-pancreatic-cancer-study-2016-10-12", "https://www.nasdaq.com/articles/alnylam-alny-to-continue-phase-iii-study-on-patisiran-2016-10-12", "https://www.nasdaq.com/articles/mylan-up-on-epipen-medicaid-settlement-cuts-2016-outlook-2016-10-12", "https://www.nasdaq.com/articles/allergan-agn-gains-rights-to-rtgel-from-urogen-pharma-2016-10-17", "https://www.nasdaq.com/articles/alnylam-alny-discontinues-phase-iii-study-on-revusiran-2016-10-06", "https://www.nasdaq.com/articles/abeona-therapeutics-abeo-surges%3A-stock-rises-11.3-2016-10-06", "https://www.nasdaq.com/articles/3-battered-biotechs-could-turn-things-around-2016-10-05", "https://www.nasdaq.com/articles/roche-rhhby-actemra-gets-breakthrough-therapy-status-2016-10-05", "https://www.nasdaq.com/articles/bayer-bayry-closes-registration-process-for-kyleena-in-eu-2016-10-05", "https://www.nasdaq.com/articles/theravance-tbph-starts-dosing-in-ulcerative-colitis-study-2016-10-05", "https://www.nasdaq.com/articles/the-zacks-analyst-blog-highlights%3A-vivus-geron-achillion-pharmaceuticals-anika", "https://www.nasdaq.com/articles/heres-why-geron-corporation-tumbled-16-september-2016-10-07", "https://www.nasdaq.com/articles/athersys-athx-shows-strength%3A-stock-moves-5.1-higher-2016-09-29", "https://www.nasdaq.com/articles/gw-pharma-attains-52-week-high-on-positive-epidiolex-data-2016-09-27", "https://www.nasdaq.com/articles/endo-appoints-new-ceo-keeps-q3-16-view-stock-jumps-2016-09-26", "https://www.nasdaq.com/articles/chiasma-chma-shows-strength%3A-stock-moves-5.9-higher-2016-09-26", "https://www.nasdaq.com/articles/biotech-stocks-under-5-2-buy-1-avoid-2016-09-24", "https://www.nasdaq.com/articles/teva-reports-positive-phase-iii-tardive-dyskinesia-data-2016-09-23", "https://www.nasdaq.com/articles/3-battered-biotechs-that-could-turn-things-around-2016-09-23", "https://www.nasdaq.com/articles/jazz-initiates-rolling-nda-for-leukemia-candidate-vyxeos-2016-10-04", "https://www.nasdaq.com/articles/biotech-stock-roundup-tobira-soars-acquisition-deal-fda-says-yes-sarepta-dmd-drug-2016-09", "https://www.nasdaq.com/articles/johnson-johnsons-smart-yet-surprising-acquisition-2016-09-20", "https://www.nasdaq.com/articles/avexis-avxs-shows-strength%3A-stock-adds-6.3-in-session-2016-09-20", "https://www.nasdaq.com/articles/celgene-presents-efficacy-safety-phase-ii-ozanimod-data-2016-09-20", "https://www.nasdaq.com/articles/pfizer-pfe-breast-cancer-drug-ibrance-wins-chmp-backing-2016-09-20", "https://www.nasdaq.com/articles/amgen-amgn-parsabiv-gets-positive-chmp-opinion-in-eu-2016-09-19", "https://www.nasdaq.com/articles/curis-cris-shows-strength%3A-stock-adds-6.9-in-session-2016-09-19", "https://www.nasdaq.com/articles/amgen-amgn-repatha-meets-endpoints-in-phase-iii-study-2016-09-21", "https://www.nasdaq.com/articles/biotech-stock-roundup-tobira-soars-acquisition-deal-fda-says-yes-sarepta-dmd-drug-2016-09", "https://www.nasdaq.com/articles/fda-panel-suggests-removing-warning-from-pfizers-chantix-2016-09-15", "https://www.nasdaq.com/articles/glaxo-gsk-publishes-phase-iii-data-on-shingles-vaccine-2016-09-15", "https://www.nasdaq.com/articles/beigene-bgne-catches-eye%3A-stock-adds-6-in-session-2016-09-15", "https://www.nasdaq.com/articles/spectrum-sppi-down-qapzola-fails-to-impress-fda-panel-2016-09-15", "https://www.nasdaq.com/articles/sarepta-shares-soar-on-news-of-key-drug-critic-fda-exit-2016-09-15", "https://www.nasdaq.com/articles/ligand-lgnd-commences-phase-ii-type-ii-diabetes-study-2016-09-14", "https://www.nasdaq.com/articles/novavax-tanks-rsv-f-vaccine-disappoints-in-two-studies-2016-09-16", "https://www.nasdaq.com/articles/bluebird-bio-blue-in-focus%3A-stock-moves-11.4-higher-2016-09-16", "https://www.nasdaq.com/articles/fda-panel-suggests-removing-warning-from-pfizers-chantix-2016-09-15", "https://www.nasdaq.com/articles/glaxo-gsk-publishes-phase-iii-data-on-shingles-vaccine-2016-09-15", "https://www.nasdaq.com/articles/horizon-hznp-to-acquire-raptor-for-%24800m-stock-soars-2016-09-13", "https://www.nasdaq.com/articles/why-geron-corporation-plunging-today-2016-09-12", "https://www.nasdaq.com/articles/mid-day-market-update-american-farmland-gains-following-merger-news-retailmenot-shares", "https://www.nasdaq.com/articles/lexicon-hits-52-week-high-on-positive-type-i-diabetes-data-2016-09-12", "https://www.nasdaq.com/articles/biotech-stock-roundup-horizon-raptor-acquisition-deal-geron-down-pipeline-news-2016-09-14", "https://www.nasdaq.com/articles/geron-gern-at-52-week-low-on-imetelstat-study-update-2016-09-13", "https://www.nasdaq.com/articles/jj-files-for-single-tablet-regimen-of-hiv-drug-prezista-in-eu-2016-09-13", "https://www.nasdaq.com/articles/lexicon-pharmaceuticals-lxrx-jumps%3A-stock-rises-16.6-2016-09-12", "https://www.nasdaq.com/articles/what-happened-stock-market-today-2016-09-12", "https://www.nasdaq.com/articles/why-geron-corporation-gern-polaris-industries-inc.-pii-and-vimpelcom-ltd-adr-vip-are-3-of", "https://www.nasdaq.com/articles/mid-afternoon-market-update-dow-surges-over-200-points-geron-shares-tumble-2016-09-12", "https://www.nasdaq.com/articles/health-care-sector-update-09122016-gern-jnj-rptp-2016-09-12", "https://www.nasdaq.com/articles/mid-morning-market-update-markets-rise-horizon-pharma-buy-raptor-pharmaceutical-9share", "https://www.nasdaq.com/articles/clovis-rucaparib-not-to-face-fda-advisory-panel-stock-up-2016-09-09", "https://www.nasdaq.com/articles/2-companies-johnson-johnson-should-consider-buying-2016-09-09", "https://www.nasdaq.com/articles/clovis-oncology-clvs-in-focus%3A-stock-moves-15-higher-2016-09-09", "https://www.nasdaq.com/articles/can-the-rally-in-geron-gern-shares-continue-2016-09-08", "https://www.nasdaq.com/articles/agios-agio-partner-celgene-to-file-for-enasidenib-stock-up-2016-09-08", "https://www.nasdaq.com/articles/ligand-retrophin-rare-disease-drug-positive-in-phase-ii-2016-09-08", "https://www.nasdaq.com/articles/bristol-myers-orencia-gains-eu-approval-for-expanded-use-2016-09-07", "https://www.nasdaq.com/articles/3-all-or-nothing-biotechs-im-watching-hawk-2016-09-11", "https://www.nasdaq.com/articles/astrazeneca-azn-presents-benralizumab-phase-iii-data-2016-09-06", "https://www.nasdaq.com/articles/merck-stops-development-of-odanacatib-for-osteoporosis-2016-09-05", "https://www.nasdaq.com/articles/mylan-myl-gets-positive-copaxone-uspto-ruling-yet-again-2016-09-02", "https://www.nasdaq.com/articles/amgen-gets-fda-approval-for-label-expansion-of-blincyto-2016-09-02", "https://www.nasdaq.com/articles/3-statistics-should-get-johnson-johnsons-long-term-shareholders-very-excited-2016-09-02", "https://www.nasdaq.com/articles/allergan-adamas-agree-to-settle-namzaric-patent-litigation-2016-09-01", "https://www.nasdaq.com/articles/pfizers-lung-cancer-drug-xalkori-label-expanded-in-the-eu-2016-09-01", "https://www.nasdaq.com/articles/biomarins-bmrn-brineura-review-period-extended-by-fda-2016-09-07", "https://www.nasdaq.com/articles/inovio-stock-up-as-second-zika-virus-vaccine-study-begins-2016-08-30", "https://www.nasdaq.com/articles/mylan-myl-obtains-favorable-uspto-ruling-for-copaxone-2016-08-25", "https://www.nasdaq.com/articles/momenta-pharmaceuticals-mnta-jumps-stock-113-2016-08-25", "https://www.nasdaq.com/articles/clovis-clvs-stock-fda-priority-review-rucaparib-2016-08-24", "https://www.nasdaq.com/articles/gilead-gild-truvada-gets-eu-approval-for-label-expansion-2016-08-23", "https://www.nasdaq.com/articles/regeneron-stock-up-on-barda-deal-for-mers-antibodies-2016-08-23", "https://www.nasdaq.com/articles/ariad-finishes-rolling-nda-for-lung-cancer-drug-brigatinib-2016-08-31", "https://www.nasdaq.com/articles/alexions-gvhd-candidate-gets-orphan-drug-status-in-the-eu-2016-08-30", "https://www.nasdaq.com/articles/inovio-stock-up-as-second-zika-virus-vaccine-study-begins-2016-08-30", "https://www.nasdaq.com/articles/mylan-myl-obtains-favorable-uspto-ruling-for-copaxone-2016-08-25", "https://www.nasdaq.com/articles/portola-ptla-stock-down-on-crl-for-andexxa-bla-in-u.s.-2016-08-18", "https://www.nasdaq.com/articles/intercept-icpt-ocaliva-phase-iii-poise-data-published-2016-08-18", "https://www.nasdaq.com/articles/anthera-pharmaceuticals-anth-jumps%3A-stock-rises-7.9-2016-08-17", "https://www.nasdaq.com/articles/alder-biopharmaceuticals-aldr-jumps%3A-stock-rises-9.6-2016-08-23", "https://www.nasdaq.com/articles/radius-rdus-osteoporosis-drug-positive-in-phase-iii-study-2016-08-17", "https://www.nasdaq.com/articles/jjs-jnj-depression-treatment-esketamine-gets-btd-2016-08-17", "https://www.nasdaq.com/articles/repros-presents-6-month-interim-data-enclomiphene-2016-08-16", "https://www.nasdaq.com/articles/ucb-epilepsy-drug-vimpats-patent-validated-by-u.s.-court-2016-08-16", "https://www.nasdaq.com/articles/vertex-vrtx-stop-vx-661-ivacaftor-study-stock-down-2016-08-16", "https://www.nasdaq.com/articles/dicerna-pharmaceuticals-drna-jumps%3A-stock-rises-7.5-2016-08-16", "https://www.nasdaq.com/articles/biodelivery-bdsi-q2-loss-meets-estimates-revenues-up-2016-08-11", "https://www.nasdaq.com/articles/inovio-ino-veterinary-vaccine-rights-licensed-to-plumbline-2016-08-17", "https://www.nasdaq.com/articles/mylan-beats-on-q2-earnings-revenues-miss-keeps-16-view-2016-08-10", "https://www.nasdaq.com/articles/repros-rprx-q2-loss-narrower-yy-focus-pipeline-2016-08-10", "https://www.nasdaq.com/articles/ionis-ions-q2-loss-narrower-than-expected-issues-outlook-2016-08-10", "https://www.nasdaq.com/articles/aegerion-aegr-q2-loss-wider-than-expected-view-intact-2016-08-10", "https://www.nasdaq.com/articles/gw-pharma-gwph-incurs-narrower-than-expected-q3-loss-2016-08-10", "https://www.nasdaq.com/articles/endo-endp-tops-q2-earnings-estimates-keeps-2016-view-2016-08-09", "https://www.nasdaq.com/articles/epizyme-epzm-q2-loss-lower-than-expected-costs-to-rise-2016-08-09", "https://www.nasdaq.com/articles/puma-pbyi-posts-narrower-loss-in-q2-focus-on-neratinib-2016-08-10", "https://www.nasdaq.com/articles/mylan-beats-on-q2-earnings-revenues-miss-keeps-16-view-2016-08-10", "https://www.nasdaq.com/articles/repros-rprx-q2-loss-narrower-yy-focus-pipeline-2016-08-10", "https://www.nasdaq.com/articles/novo-nordisk-nvo-beats-q2-earnings-revenues-up-y-y-2016-08-08", "https://www.nasdaq.com/articles/biomarin-bmrn-posts-narrower-q2-loss-sales-view-upped-2016-08-05", "https://www.nasdaq.com/articles/agios-agio-q2-loss-wider-than-expected-pipeline-in-focus-2016-08-05", "https://www.nasdaq.com/articles/aveo-aveo-reports-a-wider-loss-in-q2-tivozanib-in-focus-2016-08-05", "https://www.nasdaq.com/articles/endocyte-ecyt-reports-narrower-than-expected-loss-in-q2-2016-08-05", "https://www.nasdaq.com/articles/endocyte-ecyt-q2-loss-wider-than-expected-revised-2016-08-09", "https://www.nasdaq.com/articles/juno-juno-q2-loss-wider-expected-focus-pipeline-2016-08-05", "https://www.nasdaq.com/articles/teva-teva-beats-q2-earnings-revenues-stock-gains-2016-08-05", "https://www.nasdaq.com/articles/ligand-lgnd-q2-earnings-decline-yy-maintains-view-2016-08-05", "https://www.nasdaq.com/articles/immunogen-imgn-reports-wider-than-expected-loss-in-q4-2016-08-05", "https://www.nasdaq.com/articles/geron-gern-posts-narrower-expected-loss-q2-2016-08-04", "https://www.nasdaq.com/articles/4-top-stocks-under-5-2016-08-04", "https://www.nasdaq.com/articles/drug-stocks-to-watch-for-earnings-on-aug-3%3A-zts-exel-more-2016-08-02", "https://www.nasdaq.com/articles/radius-health-rdus-reports-wider-than-expected-q2-loss-2016-08-05", "https://www.nasdaq.com/articles/juno-juno-q2-loss-wider-expected-focus-pipeline-2016-08-05", "https://www.nasdaq.com/articles/teva-teva-beats-q2-earnings-revenues-stock-gains-2016-08-05", "https://www.nasdaq.com/articles/ligand-lgnd-q2-earnings-decline-yy-maintains-view-2016-08-05", "https://www.nasdaq.com/articles/immunogen-imgn-reports-wider-than-expected-loss-in-q4-2016-08-05", "https://www.nasdaq.com/articles/3-small-cap-stocks-buy-july-2016-06-25", "https://www.nasdaq.com/articles/9-easy-ways-lose-money-stock-market-2016-06-17", "https://www.nasdaq.com/articles/4-catalysts-send-incyte-corporation-17-higher-may-2016-06-03", "https://www.nasdaq.com/articles/geron-gern-q2-earnings-whats-store-stock-2016-08-01", "https://www.nasdaq.com/articles/geron-gern-q1-loss-line-imetelstat-remains-focus-2016-05-06", "https://www.nasdaq.com/articles/drug-stocks-earnings-preview%3A-gern-rprx-icpt-agio-more-2016-05-04", "https://www.nasdaq.com/articles/geron-gern-q1-earnings-whats-store-stock-2016-05-03", "https://www.nasdaq.com/articles/are-these-3-biotechs-destined-be-bought-out-2016-04-24", "https://www.nasdaq.com/articles/3-likely-reasons-why-geron-corporation-vaulted-higher-18-march-2016-04-07", "https://www.nasdaq.com/articles/these-4-healthcare-stocks-are-all-soaring-today-and-heres-why-2016-04-04", "https://www.nasdaq.com/articles/buying-these-2-drug-developers-would-make-lot-sense-johnson-johnson-2016-03-31", "https://www.nasdaq.com/articles/these-growth-stocks-could-double-over-next-12-months-2016-05-29", "https://www.nasdaq.com/articles/4-surging-stocks-brokers-love-healthcare-sector-2016-03-28", "https://www.nasdaq.com/articles/gilead-and-4-other-buy-stocks-biotech-industry-2016-03-22", "https://www.nasdaq.com/articles/3-biotech-stocks-buy-sale-2016-03-18", "https://www.nasdaq.com/articles/3-stocks-could-make-you-rich-2016-03-15", "https://www.nasdaq.com/articles/3-reasons-geron-corporation-stock-could-rise-2016-03-08", "https://www.nasdaq.com/articles/geron-q4-loss-line-estimates-imetelstat-focus-2016-02-26", "https://www.nasdaq.com/articles/geron-gern-report-q4-earnings-whats-store-2016-02-23", "https://www.nasdaq.com/articles/the-zacks-analyst-blog-highlights%3A-corcept-therapeutics-epizyme-geron-and-synthetic", "https://www.nasdaq.com/articles/why-incytes-shares-are-tumbling-today-2016-02-11", "https://www.nasdaq.com/articles/why-shares-geron-corp-cratered-january-2016-02-11", "https://www.nasdaq.com/articles/shares-incyte-corporation-plummeted-january-heres-why-2016-02-07", "https://www.nasdaq.com/articles/2-beaten-down-biotech-stocks-buy-february-2016-02-06", "https://www.nasdaq.com/articles/2-speculative-small-cap-biotech-stocks-could-double-2016-01-21", "https://www.nasdaq.com/articles/geron-up-myelodysplastic-syndromes-phase-ii-iii-study-begins-2016-01-15", "https://www.nasdaq.com/articles/johnson-johnsons-ceo-just-tipped-his-cap-big-way-regarding-ma-2016-01-12", "https://www.nasdaq.com/articles/3-all-or-nothing-biotech-stocks-were-closely-watching-2016-02-20", "https://www.nasdaq.com/articles/why-incytes-shares-are-tumbling-today-2016-02-11", "https://www.nasdaq.com/articles/why-shares-geron-corp-cratered-january-2016-02-11", "https://www.nasdaq.com/articles/3-biotech-stocks-under-5-could-explode-higher-2016-2015-12-27", "https://www.nasdaq.com/articles/will-johnson-johnson-raise-its-dividend-2016-2015-12-19", "https://www.nasdaq.com/articles/novembers-best-healthcare-etf-2015-12-10", "https://www.nasdaq.com/articles/potential-new-data-lifts-geron-corporation-november-2015-12-04", "https://www.nasdaq.com/articles/geron-corporation-exploded-49-higher-2015-heres-why-2016-01-11", "https://www.nasdaq.com/articles/noteworthy-monday-option-activity-gern-vra-cit-2015-11-30", "https://www.nasdaq.com/articles/time-provides-best-cure-gerons-recent-weakness-2015-11-11", "https://www.nasdaq.com/articles/geron-beats-q3-earnings-revenues-imetelstat-focus-2015-11-06", "https://www.nasdaq.com/articles/will-geron-gern-post-wider-expected-loss-q3-2015-11-02", "https://www.nasdaq.com/articles/can-the-rally-in-geron-gern-shares-continue-2015-10-27", "https://www.nasdaq.com/articles/unknown-small-cap-stocks-should-be-your-radar-2015-10-15", "https://www.nasdaq.com/articles/should-geron-corporation-gern-be-on-your-radar-now-2015-10-07", "https://www.nasdaq.com/articles/will-geron-gern-continue-to-surge-higher-2015-12-03", "https://www.nasdaq.com/articles/health-care-sector-update-09162015-bmy-agn-gern-2015-09-16", "https://www.nasdaq.com/articles/small-cap-biotech-could-wind-devouring-much-larger-foes-revenue-stream-2015-09-11", "https://www.nasdaq.com/articles/the-zacks-analyst-blog-highlights%3A-amgen-tetraphase-geron-alexion-and-acadia-2015-09-10", "https://www.nasdaq.com/articles/biotech-stock-roundup-biosimilar-competition-amgen-tetraphase-hit-disappointing-data-2015", "https://www.nasdaq.com/articles/heres-why-geron-corporations-stock-ripping-higher-today-2015-09-03", "https://www.nasdaq.com/articles/us-stock-futures-extend-gains-jobless-claims-rise-more-expected-2015-09-03", "https://www.nasdaq.com/articles/pre-market-most-active-sep-3-2015-gern-xiv-bp-bac-aapl-nok-qqq-tvix-fb-bhp-sune-nvs-2015", "https://www.nasdaq.com/articles/can-geron-gern-run-higher-on-strong-earnings-estimate-revisions-2015-09-25", "https://www.nasdaq.com/articles/health-care-sector-update-09162015-bmy-agn-gern-2015-09-16", "https://www.nasdaq.com/articles/small-cap-biotech-could-wind-devouring-much-larger-foes-revenue-stream-2015-09-11", "https://www.nasdaq.com/articles/the-zacks-analyst-blog-highlights%3A-amgen-tetraphase-geron-alexion-and-acadia-2015-09-10", "https://www.nasdaq.com/articles/3-experimental-cancer-drugs-investors-should-be-closely-watching-2015-07-02", "https://www.nasdaq.com/articles/biotech-stock-has-jaw-dropping-growth-potential-2015-06-30", "https://www.nasdaq.com/articles/can-the-rally-in-geron-gern-shares-continue-tale-of-the-tape-2015-06-24", "https://www.nasdaq.com/articles/us-stock-futures-modestly-higher-ecb-leaves-rates-unchanged-weekly-jobless-data-tap-2015", "https://www.nasdaq.com/articles/geron-q1-loss-in-line-with-estimates-restructuring-on-track-analyst-blog-2015-05-01", "https://www.nasdaq.com/articles/health-care-sector-update-05012015-gernnktrtlog-2015-05-01", "https://www.nasdaq.com/articles/the-zacks-analyst-blog-highlights%3A-gilead-sciences-biogen-geron-johnson-johnson-and", "https://www.nasdaq.com/articles/forget-gilead-gild-buy-these-impressive-biotech-stocks-instead-analyst-blog-2015-04-21", "https://www.nasdaq.com/articles/health-care-sector-update-04212015-gern-myl-teva-nvgn-jnj-2015-04-21", "https://www.nasdaq.com/articles/3-biotech-stocks-under-%2410-with-amazing-growth-prospects-analyst-blog-2015-04-15", "https://www.nasdaq.com/articles/reason-behind-geron-corporations-25-catapult-higher-march-2015-04-09", "https://www.nasdaq.com/articles/why-geron-gern-might-be-a-diamond-in-the-rough-tale-of-the-tape-2015-05-26", "https://www.nasdaq.com/articles/geron-q1-loss-in-line-with-estimates-restructuring-on-track-analyst-blog-2015-05-01", "https://www.nasdaq.com/articles/health-care-sector-update-05012015-gernnktrtlog-2015-05-01", "https://www.nasdaq.com/articles/whats-in-store-for-geron-gern-this-earnings-season-analyst-blog-2015-03-02", "https://www.nasdaq.com/articles/3-all-or-nothing-biotech-stocks-were-closely-watching-2015-02-09", "https://www.nasdaq.com/articles/small-cap-stock-im-watching-2015-2015-01-07", "https://www.nasdaq.com/articles/3-biotech-stocks-could-double-2015-2014-12-29", "https://www.nasdaq.com/articles/market-has-not-yet-noticed-potential-in-geron-gern-have-you-tale-of-the-tape-2015-04-07", "https://www.nasdaq.com/articles/why-geron-corporation-gern-stock-might-be-a-great-pick-tale-of-the-tape-2014-12-10", "https://www.nasdaq.com/articles/geron-gern-stock%3A-moving-average-crossover-alert-tale-of-the-tape-2014-12-05", "https://www.nasdaq.com/articles/health-care-sector-update-12052014-gernatospbmd-2014-12-05", "https://www.nasdaq.com/articles/why-geron-corporation-stock-surged-65-november-2014-12-02", "https://www.nasdaq.com/articles/3-biotech-stocks-jaw-dropping-growth-potential-2015-2014-11-29", "https://www.nasdaq.com/articles/3-healthcare-stocks-short-sellers-are-wrong-about-2014-11-21", "https://www.nasdaq.com/articles/biotech-stock-roundup-geron-soars-935m-jj-deal-gileads-harvoni-approved-eu-analyst-blog", "https://www.nasdaq.com/articles/market-has-not-yet-noticed-potential-in-geron-gern-have-you-tale-of-the-tape-2014-12-17", "https://www.nasdaq.com/articles/geron-collaborates-with-jj-for-imetelstat-analyst-blog-2014-11-14", "https://www.nasdaq.com/articles/health-care-sector-update-11142014-gernjnjimucvasc-2014-11-14", "https://www.nasdaq.com/articles/biotech-stock-roundup-regenerons-eylea-stumbles-geron-lifting-clinical-hold-analyst-blog", "https://www.nasdaq.com/articles/mid-morning-market-update-markets-mixed-publicis-acquire-sapient-37-billion-2014-11-03", "https://www.nasdaq.com/articles/why-geron-corporation-shares-skyrocketed-2014-11-03", "https://www.nasdaq.com/articles/pre-market-most-active-nov-3-2014-sape-arcp-gern-sap-wac-nok-un-fb-baba-pbr-tvix-aapl-2014", "https://www.nasdaq.com/articles/mid-day-market-update-ford-falls-october-sales-report-geron-shares-climb-2014-11-03", "https://www.nasdaq.com/articles/can-the-rally-in-geron-gern-shares-continue-tale-of-the-tape-2014-11-19", "https://www.nasdaq.com/articles/next-industry-google-plans-transform-2014-09-28", "https://www.nasdaq.com/articles/why-geron-corporation-stock-down-shocking-52-2014-2014-09-23", "https://www.nasdaq.com/articles/why-you-shouldnt-bet-against-geron-corporation-gern-stock-tale-of-the-tape-2014-09-08", "https://www.nasdaq.com/articles/geron-corp.-gern-jumps%3A-stock-moves-8.1-higher-tale-of-the-tape-2014-07-01", "https://www.nasdaq.com/articles/geron-gern-enters-overbought-territory-tale-of-the-tape-2014-06-25", "https://www.nasdaq.com/articles/geron-gern-falls%3A-stock-goes-down-5.4-tale-of-the-tape-2014-06-16", "https://www.nasdaq.com/articles/geron-gains-as-fda-lifts-partial-hold-on-imetelstat-study-analyst-blog-2014-06-13", "https://www.nasdaq.com/articles/sarepta-therapeutics-inc-stock-short-sell-2014-10-13", "https://www.nasdaq.com/articles/us-futures-point-lower-open-data-disappoint-global-growth-forecast-cut-2014-06-12", "https://www.nasdaq.com/articles/sector-update-healthcare-shares-flat-pre-market-geron-gets-partial-clinical-hold-lifted", "https://www.nasdaq.com/articles/sector-update-healthcare-2014-06-12", "https://www.nasdaq.com/articles/us-stock-futures-slip-weak-jobless-numbers-retail-figures-world-bank-lowering-global", "https://www.nasdaq.com/articles/pre-market-most-active-jun-12-2014-exc-lulu-gern-fb-bac-apu-bhp-rio-achn-aapl-lyg-tvix", "https://www.nasdaq.com/articles/biotech-etfs-bounce-back-after-three-month-correction-2014-06-11", "https://www.nasdaq.com/articles/mid-day-market-update-rackspace-gains-upbeat-earnings-dxp-enterprises-shares-slip-2014-05", "https://www.nasdaq.com/articles/geron-corp.-gern-soars%3A-stock-up-10.6-tale-of-the-tape-2014-06-12", "https://www.nasdaq.com/articles/us-futures-point-lower-open-data-disappoint-global-growth-forecast-cut-2014-06-12", "https://www.nasdaq.com/articles/sector-update-healthcare-shares-flat-pre-market-geron-gets-partial-clinical-hold-lifted", "https://www.nasdaq.com/articles/sector-update-healthcare-2014-06-12", "https://www.nasdaq.com/articles/after-hours-earnings-report-march-25-2014-pvh-five-scs-gern-lndc-gol-exfo-axu-htm-gevo", "https://www.nasdaq.com/articles/tuesdays-etf-movers-gdxj-xbi-2014-03-25", "https://www.nasdaq.com/articles/pre-market-most-active-mar-19-2014-vz-rdsa-hznp-orcl-qqq-nok-sny-fcel-kndi-gern-siri-bp", "https://www.nasdaq.com/articles/mid-afternoon-market-update-markets-trade-choppy-session-elizabeth-arden-shares-remain", "https://www.nasdaq.com/articles/geron-reports-in-line-q1-loss-analyst-blog-2014-05-05", "https://www.nasdaq.com/articles/mid-afternoon-market-update-markets-mixed-geron-shares-take-beating-following-fda-release", "https://www.nasdaq.com/articles/healthcare-stocks-slipping-ahead-closing-bell-geron-tumbles-after-fda-shelves-work-blood", "https://www.nasdaq.com/articles/sector-update-healthcare-2014-03-12", "https://www.nasdaq.com/articles/after-hours-earnings-report-march-12-2014-wsm-mtn-hmin-mtdr-kkd-sgms-iret-depo-nsu-orex", "https://www.nasdaq.com/articles/use-options-chance-buy-gern-52-discount-2014-02-26", "https://www.nasdaq.com/articles/clinical-trial-hold-gerons-revolutionary-drug-imetelstat-will-be-temporary-2014-03-18", "https://www.nasdaq.com/articles/tuesdays-etf-movers-xbi-gdxj-2014-03-18", "https://www.nasdaq.com/articles/geron-plunges-on-fda-clinical-hold-analyst-blog-2014-03-13", "https://www.nasdaq.com/articles/mid-afternoon-market-update-markets-post-rally-go-green-precious-metals-take-hit-2014-01", "https://www.nasdaq.com/articles/healthcare-stocks-slightly-lower-geron-sinks-after-researcher-ends-patient-enrollment-2014", "https://www.nasdaq.com/articles/sector-update-healthcare-2014-01-27", "https://www.nasdaq.com/articles/geron-corporation-gern-new-analyst-report-zacks-equity-research-zacks-equity-research", "https://www.nasdaq.com/articles/strength-seen-in-geron-corporation-gern%3A-stock-surges-23.6-tale-of-the-tape-2014-01-31", "https://www.nasdaq.com/articles/mid-morning-market-update-markets-edge-lower-toll-brothers-profit-tops-estimates-2013-12", "https://www.nasdaq.com/articles/pre-market-most-active-dec-10-2013-nok-asx-gern-aalcp-arcc-smfg-aria-nj-bac-alu-mu-brcm", "https://www.nasdaq.com/articles/stocks-pressured-lower-dow-closes-below-16000-2013-12-10", "https://www.nasdaq.com/articles/sector-update-healthcare-stocks-higher-ziopharm-climbs-5-approval-study-brain-cancer-2013", "https://www.nasdaq.com/articles/sector-update-healthcare-2013-12-06-1", "https://www.nasdaq.com/articles/pre-market-most-active-dec-6-2013-qqq-bac-nok-intc-gern-jcp-alu-fb-rad-doc-xiv-drys-2013", "https://www.nasdaq.com/articles/largest-option-trades-equities-2013-11-12", "https://www.nasdaq.com/articles/is-geron-corporation-gern-stock-a-solid-choice-right-now-tale-of-the-tape-2013-12-31", "https://www.nasdaq.com/articles/healthcare-stocks-near-session-bests-geron-pops-new-52-week-high-after-new-coverage-mlv-co", "https://www.nasdaq.com/articles/sector-update-healthcare-2013-10-16-1", "https://www.nasdaq.com/articles/narrower-q2-loss-at-geron-analyst-blog-2013-08-12", "https://www.nasdaq.com/articles/neuralstem-anticipating-more-efficacy-data-als-trial-and-update-new-clinical-trials-2013", "https://www.nasdaq.com/articles/geron-narrows-loss-cuts-jobs-analyst-blog-2013-04-29", "https://www.nasdaq.com/articles/weekly-ceo-buys-highlight-ibtx-insm-gern-ino-equ-2013-04-07", "https://www.nasdaq.com/articles/lower-loss-at-geron-analyst-blog-2013-03-14", "https://www.nasdaq.com/articles/geron-q3-loss-in-line-shares-up-on-ash-abstract-analyst-blog-2013-11-11", "https://www.nasdaq.com/articles/healthcare-stocks-near-session-bests-geron-pops-new-52-week-high-after-new-coverage-mlv-co", "https://www.nasdaq.com/articles/sector-update-healthcare-2013-10-16-1", "https://www.nasdaq.com/articles/geron-biotime-sign-loi-analyst-blog-2012-11-16", "https://www.nasdaq.com/articles/geron-posts-narrower-loss-analyst-blog-2012-10-31", "https://www.nasdaq.com/articles/geron-hit-by-pipeline-setback-analyst-blog-2012-09-11", "https://www.nasdaq.com/articles/buy-or-sell-mondays-losers-titn-gern-2012-09-10", "https://www.nasdaq.com/articles/geron-posts-in-line-loss-analyst-blog-2012-08-01", "https://www.nasdaq.com/articles/after-hours-earnings-report-march-12-2013-kw-dole-acad-gca-gnmk-avid-wsr-ktos-gern-acrx", "https://www.nasdaq.com/articles/neutral-on-geron-corp.-analyst-blog-2012-04-02", "https://www.nasdaq.com/articles/geron-misses-estimates-analyst-blog-2012-03-09", "https://www.nasdaq.com/articles/stem-cell-therapy-may-prevent-heart-failure-4-companies-watch-2011-11-16", "https://www.nasdaq.com/articles/medical-breakthrough-successful-stem-cell-transplant-sweden-2011-07-08", "https://www.nasdaq.com/articles/8-cash-comfortable-stocks-under-5-2011-06-07", "https://www.nasdaq.com/articles/stocks-shed-early-upside-mid-day-investors-eye-bernanke-testimony-oil-price-spike-2011-03", "https://www.nasdaq.com/articles/mid-day-update-stocks-sinking-despite-positive-supply-data-bernanke-talks-inflation-2011", "https://www.nasdaq.com/articles/geron-narrows-loss-on-lower-costs-analyst-blog-2012-05-03", "https://www.nasdaq.com/articles/geron-buyer-beware-2010-10-13", "https://www.nasdaq.com/articles/joe-feshbachs-highest-conviction-position-regenerative-medicine-game-changer-2010-01-12", "https://www.nasdaq.com/articles/momentum-ideas-15-undervalued-stocks-approaching-inflection-point-2010-11-22"], "Content": []}